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SUMMARY 
The ethanolic extract from the stem bark of Cassipourea 
gerrardi i (RHIZOPHORACEAE) yielded a phenolic fraction, the 
components of which were extremely intractable. 
using a combination of chromatographic techniques a series of 
compounds were isolated and include the known compounds 
afzelechin (i) , epiafzelechin (ii) , and epiafzelechin-
(4~~8,2~~O~7)-epiafzelechin (iii). The only previous 
isolation of the latter compound was from Ephedra spp. and 
this compound is reported to possess hypotensive properties. 
Three new compounds were also isolated and identified as 
afzelechin-3-0-a-L-rhamnopyranoside (iv) , epiafzelechin-
(4~~8,2~~O~7)-ent-afzelechin (v) and epiafzelechin-
(4~~6)-epiafzelechin-(4~~8,2~~O~7)-ent-afzelechin (vi). The 
latter compound is the only known example of a trimeric 
A-type propelargonidin. 
A chemical investigation of the phenolic constituents in the 
stem bark of C . gummif 1 ua has led to the re-isolation of 
compounds (i)-(v), the isolation of the biogenetically 
closely related flavonol, kaempferol-3-0-a-L-rhamnopyranoside 
(vii) and two new A-type proanthocyanidins identified as 
7-0Me-epiafzelechin-(4~~8,2~~O~7)-ent-afzelechin (viii) and 
7-0Me-epiafzelechin-(4~~8,2~~O~7)-epiafzelechin (ix). The 
latter two compounds are the only examples of naturally 
occurring O-methylated A-type proanthocyanidins. 
A similar investigation into the phenolic constituents in the 
stem bark of C. mossambicensis has led to the isolation of a 
rarely occurring O-methylated flavan-3-ol identified as 
4'-OMe-epigallocatechin (x). The isolation of this compound 
has hitherto been restricted to species in the Celastracea 
and is accompanied in the stem bark of C. mossambicensis by 
compounds (i)-(vi). 
v 
The structures have been established on the basis of 
spectroscopic and chemical evidence. 
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The bewildering variety of chemical compounds produced by 
nature has awakened the chemists' enthusiasm and curiosity, 
particularly in his search for biologically-active compounds. 
A large number of these natural products has emerged from the 
scientific study of remedies traditionally employed by 
various cultures. Atropine, quinine, digoxin, colchicine and 
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In cases where the biological activity is too low, or the 
toxicity too high to be of practical use, such compounds may 
serve as prototype molecules or templates for the development 
of new bio-active compounds . A good example of this strategy 
is provided by the aryltetralin lignan podophyllotoxin (1) 
extracted from the rhizomes of Podophyllum peltatum and P . 
emodii 1 • Although this compound showed anti-tumour activity 
in rodents, severe non-specific side effects and no 
significant response was observed in humans 2 • Systematic 
2 
chemical modification of the aryltetralin yielded a series of 
compounds with promising activity in vitro and in vivo. Two 
of these, etoposide (2) and teniposide (3) have been 
developed as anticancer drugs and are at present in clinical 
use. 
Cassipourea gerrardii (Rhizophoraceae), commonly referred to 
as the bastard onion wood on account of its smell, is a small 
indigenous canopy tree 3 • The bark from this species is 
extensively sold in herbal medicine shops where it is known 
as "memzi obomvu" because of its orange-red colour. Previous 
work on the extractives of Cassipourea species by Warren and 
his associates 4 . 5 resulted in the isolation of the novel 
sulphur- containing alkaloids, cassipourine (4 ) from C . 
gummiflua 4 and gerrardine (5) from C. gerrardii s . 
H i)-JH . __ - "s - s" .. " " 
N N •• , H H I/o 
s-s Me 
(4 ) (5) 
The present study was undertaken as part of an ongoing 
program within this Department aimed at isolating 
biologically-active compounds from indigenous medicinal 
plants. The initial objectives were to re-investigate the 
chemical constituents in the stem bark of C. gerrardii, with 
emphasis on the isolation of phenolic components. 
As ubiquitous plant constituents, phenolic compounds are 
present in many foods, drinks, spices and natural plant 
drugs. Although their biological activity is less pronounced 
and less specific than those of the alkaloids, nearly all 
phenolic compounds, including phenol itself, as well as the 
polyphenolic tannins possess some biological activity. 




Gossypol (6), a polyphenolic dimeric sesquiterpene derived 
primarily from Gossypium species serves as a classic example 
to illustrate the potential biological activity of phenolic 
compounds. The contraceptive effect of gossypol was 
discovered through the observation of subnormal fertility in 
rural communities in China where crude cottonseed oil was 
used for preparing food . In extensive clinical tests in China 
on more than 8800 men, (±)-gossypol was reported to be 99 . 89% 
effective as a male contraceptive. Gossypol, apart from being 
a typical phenolic compound, also shows atropisomerism as a 
result of restricted rotation about the biaryl axis . In many 
ways gossypol serves as an ideal model for the polyphenols 
isolated in this work. Functional group reactivity, in this 
case phenolic, coupled with preferred conformation as a 
result of restricted rotation, yield compounds with unique 
biological properties . Thus gossypol, as the (-)-enantiomer 
only, possesses pronounced antifertility activity 6 . In 
addition, the biological activity of phenolic compounds 
appear, at least in part, to be derived from their ability to 
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uncommon structural features such as the substitution 
patterns, stereochemistry, as well as the positions of the 
inter-flavonoid linkages, yielded a series of compounds which 
were either rarely occurring or novel. From a merely academic 
viewpoint, these compounds provided a challenge with regard 
3 
to their isolation, and in particular, the stereochemical 
aspects of their structure determination. 
In order to provide a better understanding of the more 
complex compounds discussed in this work, a brief survey of 
one of the largest and most important classes of phenolic 
compounds, the flavonoids, is given below . 
1.2. THE FLAVONOIDS 
The flavonoids constitute one of the most numerous and 
widespread groups of compounds in the plant kingdom. The 
chemical structures are based on a C6-C3-C6 skeleton with a 
chroman ring bearing a second aromatic ring in position 2, 3 
or 4 (Fig. 1.). In a few cases, the six membered heterocyclic 






Fig. 1. Basic structure of most flavonoids 
The flavonoids are divided into a number of classes based on 
the degree of oxidation of the C-ring and the position of the 








Flavan - 3-o1 Aurone 
Variations in substitution patterns, stereochemistry and in 
the nature of the substituents, result in an extensive range 
of compounds within each class of flavonoid . A comprehensive 
list of all known flavonoids by Harborne 7 totalling over 4000 
structures bears testament to the diversity of this unique 
class of compounds. 
1 . 2.1. Flavonoid biosynthesis 
Earlier work based on results from radioactive tracer 
studies, and more recently work at the enzyme level has 
resulted in considerable progress in the elucidation of the 
biosynthetic pathways of the flavonoids. This subj ect has 
been the topic of a number of reviews in recent years 8 , 9,lO . 
Thus, the aim of this section is merely to provide a broad 
overview of the biosynthesis of the flavonoids, to show the 
relationship between the various flavonoid classes and to 
highlight some recent developments. 
I n 1962 Grisebach ll extended the earlier ideas of Birch12 and 
proposed that the first specific reaction in flavonoid 
biosynthesis was the enzyme mediated condensation of an 
activated cinnamic acid with three molecules of malonyl-CoA 
to yield a chalcone or flavanone 12 . Earlier experiments with 
radioactively labelled precursors served to substantiate this 
proposal . The biosynthetic relationship of the flavonoids as 
concluded from these experiments (Scheme 1.) may be 
summarised as follows : 
i) Ring A is derived from the head-to-tail condensation 
of three acetate units (v i a malonate) . Ring B and the 
heterocyclic C- ring carbons at position 2 , 3 and 4 are 
derived from phenylalanine. 
ii) All flavonoid classes are biosynthetically closely 
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Scheme 1. The biosynthetic relationships of the flavonoids as concluded 
from in vivo labelling experiments. 
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Scheme 2. General phenyl propanoid metabolism . Key enzymes : 
(1) Phenylalanine ammonia-lyase, (2) cinnamate 4-hydroxylase , 
(3) hydroxycinnamate:CoA ligase. 
8 
Malonyl-CoA, one of two substrates for chalcone synthase, is 
derived from acetyl-eoA via the action of a carboxylase 
enzyme. Although a typical enzyme of fatty acid biosynthesis, 
thi s enzyme is 
biosynthesis. 
also an integral part 
9 
of flavonoid 
The pathway leading to the second substrate, usually 4-
coumaroyl-CoA is shown (Scheme 2.). In this sequence of 
reactions phenylalanine, derived from the shikimate pathway, 
is converted to a series of substituted cinnamic acid 
derivatives. These derivatives are subsequently activated to 
yield their corresponding CoA esters. Besides the flavonoids, 
these activated cinnamic acid derivatives serve as precursors 
for various other classes of phenylpropanoids such as lignan, 
stilbenes and benzoic acids. For this reason this sequence of 
reactions was termed "general phenylpropanoid metabolism" 1 3 . 
The enzymes catalysing the individual steps are phenylalanine 
ammonia-lyase, cinnamate 4-hydroxylase and hydroxy-
cinnamate:CoA ligase. 
Phenylalanine ammonia-lyase is one of the best studied 
enzymes in phenolic metabolism. It catalyses the elimination 
of NH3 from L-phenylalanine to give trans-cinnamate. The 
enzyme from many sources, notably grasses, also acts on 
L-tyrosine to yield trans-p-coumarate. Phenylalanine 
ammonia-lyase has attracted considerable attention because it 
provides the link between primary metabolism and the 
phenylpropanoid pathways. The properties as well as the role 
of this enzyme have been reviewed by Hanson and Havir 14 . 
The second enzyme of general phenylpropanoid metabolism, 
cinnamate 4-hydroxylase, catalyses the 4-hydroxylation of 
trans-cinnamate to yield trans-4-coumarate. This enzyme, 
described as a "microsomal cytochromic P-450-dependent 
mono-oxygenase that utilises NADPH as a hydrogen donor", has 
been reviewed together with other oxygenases by Butt and 
Lamb lS • This enzyme, first discovered in pea seedlings 1 6, is 
the best characterised of plant mono-oxygenases. Of 
particular interest is the effect of physiological stimuli on 
the activity of this enzyme in plants, cell suspensions and 
10 
excised organs. For example, the accumulation of flavonoids 
and hydroxycinnamic esters in buckwheat seedlings 1 7 and of 
flavonoids in parsley cell cultures l8 is triggered by 
illumination and correlated with increases in cinnamate 
4-hydroxylase activity. 
The enzymes involved in the conversion of trans-4-coumarate 
to caffeic acid and its derivatives, such as the partially 
methylated ferulic acid in which the p-hydroxy group is free, 
are not well understood . Phenolase preparations have been 
found to catalyse the hydroxylation of p-coumaric acid to 
caffeic acid, usually in the presence of an additional 
reductant, such as ascorbate l9 or dimethyltetrahydro-
pteridine 2o . Nevertheless, in terms of flavonoid biosynthesis 
these conversions are of minor importance since evidence 
suggests that 4-coumarate is the main, if not exclusive 
precursor for chalcone formation. Finally, activation of the 
cinnamic acid derivatives via the corresponding CoA esters is 
catalysed by hydroxy cinnamate:CoA ligase and which is often 
called 4-coumarate:CoA ligase, referring to its preferred 
substrate. 
1 . 2.1.2. Flavonoid pathways 
The condensation of 4-coumaroyl-CoA with three successive 
molecules of malonyl-CoA to yield naringenin-chalcone is the 
first step of the true flavonoid pathway. The chalcone is the 
central intermediate for the formation of all flavonoid 
classes, and thus chalcone synthase, the enzyme that 
catalyses this step, may be regarded as the key enzyme of 
flavonoid biosynthesis. Chalcone synthase has been isolated 
from several different plant sources. In all cases where this 
enzyme has been tested, 4-coumaroyl-CoA has proven to be the 
best substrate, although caffeoyl-CoA and even feruloyl-CoA 
may be accepted as substrates. That 4-coumaroyl-CoA is the 
11 
main physiological substrate for chalcone synthase is based 
mainly on the following evidence: 
i) In vivo use of caffeoyl-CoA in addition to 
4-coumaroyl-CoA has only been demonstrated in Verbena 21 and 
tUlip22 ,2 3. 
ii) Flavonoid-3' - and -3',5' -hydroxylases as well as 
various methyltransferases have been demonstrated in a wide 
variety of plant species. 
The second enzyme, chalcone isomerase, is the second key 
enzyme of flavonoid biosynthesis and catalyses the 
stereospecific conversion of chalcones to their corresponding 
(28) -flavanones. Comparative studies of chalcone isomerases 
from cell suspension cultures of bean (Phaseolus vulgaris), 
soybean (Glycine max) and lucerne (Medicago sativa) have 
shown that the enzyme activity is induced by fungal 
elicitors, and that they catalyse isomerisation of both 
naringenin-chalcone and liquiritigenin24. The enzyme from 
Petunia hybrida, however, was non-inducible and specific for 
naningenin-chalcone, suggesting differences and anomalies 
between the properties of chalcone isomerases from different 
sources. 
purified 
Rate constants and stereoselectivity of highly 
from soybean have been chalcone isomerase 
determined 25 . Interestingly, this enzyme catalysed 
cyclisation of isoliquiritigenin to (2S)-liquiritigenin with 
a rate constant 36 x 10 6-fold greater than that for 
spontaneous isomerisation. 
In many plants, the occurrence of flavonoids having 
resorcinol rather than phloroglucinol substitution patterns 
in the acetate derived aromatic ring has prompted 
speculation about the possible existence of a 
6'-deoxychalcone synthase enzyme. Recently, a reductase 
enzyme acting concomitantly with chalcone synthase has been 
detected. The results from these studies have been reviewed 
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Scheme 3 . Enzymes: (1) chalcone synthase, (2) reductase, 
(3) chalcone isomerase . 
i) The reductase, which requires NADPH as a co-factor 
has been purified and shown to be a single polypeptide . 
ii) This enzyme catalyses transfer of the pro-R(A) 
hydrogen of NADPH to the substrate, either 4-coumaroyl-CoA or 
caffeoyl-CoA. 
iii) Reduction occurs at the polyketide stage since the 
reductase gives no products when incubated with 
naringenin-chalcone/naringenin and NADPH . 
iv) The sequence of Scheme 3 is proposed, although it is 
unknown whether the dehydration step occurs before or after 
cyclisation, 
catalysed. 
or whether it is spontaneous or enzyme 
With the exception of the anthocyanins, where a few reactions 
remain unclear, the key steps leading to the major flavonoid 
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1.2.2. The biological function of flavonoids 
The reason why plants produce these secondary metabolites in 
such vast quantities, and with such structural variation, has 
been the focus of a great deal of attention in recent years. 
It is clear that the role of the flavonoids is multi-
functional. They exhibit a wide variety of biochemical, 
physiological and ecological activities which enable plants 
to survive the various challenges of their environment. 
A major function of the flavonoids is in imparting colour to 
flowers and fruit in order to attract animals (mainly insects 
and bees), for the purpose of pollination and seed dispersal. 
Flower colour has recently been reviewed 28 . Anthocyanins 
provide most of the pink, orange, red, violet and blue 
colours to flowers. The chalcones, aurones and yellow 
flavonols sometimes contribute to yellow flower colour, and 
these, together with the colourless flavone and flavonol 
glycosides, are frequently responsible for U.V. patterns 
which guide insects, especially bees, in their search for 
nectar. 
The flavonoids are conjugated aromatic compounds and as such 
may act as potent screening agents against harmful U.V. 
radiation. The U.V. induced activity of a number of enzymes 
involved in 
demonstrated 17 , lB, 
flavonoid biosynthesis has been 
and may serve to confirm this theory . The 
flavanoids are typical phenolic compounds and therefore act 
as potent antioxidants and metal chelators. 
Flavonoids play a role in plant defence against microbial 
attack. The antimicrobial properties of the proanthocyanidins 
have been discussed in a recent review 29 . A number of 
flavonoid phytoalexins have been identified. Phytoalexins are 
antimicrobial (especially antifungal) compounds produced by 
plants as a response to fungal or bacterial attack and may be 
considered as part of a plant's natural defence against 
15 
micro-organisms. Most of the flavonoid phytoalexins are 
isoflavonoids although other classes of flavonoid have been 
demonstrated. For example, 
(6) have been identified 
Shuteria vestita 30 • 
~"'" a 
four dihydroflavonols, including 






In another example, three flavans (7), (8) and (9) were 
isolated as phytoalexins of Narcissus pseudonarcissus after 
inoculation with Botrytis cinerea 31 • 
HO 
(7) Rl=R2=H 
(8) R1 =OH; R2=H 
(9) R1 =OH; R2=Me 
Plant flavonoids affect insect behaviour, development and 
growth. The insecticidal activity of the rotenoids, which may 
be traced to an inhibition of the mitochondrial electron 
transport system, has been discussed by McClure 32 . Rotenone 






Besides the insecticidal activity of the rotenoids, the role 
of flavonoids as feeding stimulants, feeding deterrents and 
larval growth inhibitors have been demonstrated in a variety 
of plant species. For example, a flavan-3-ol glycoside (11) 
isolated from Ulmus americana is believed to act as a feeding 
stimulant for the smaller European elm bark beetle Scolytus 
multistriatus (Marsham) 33 , 34 . The feeding deterrent activity 
of a number of naturally occurring flavonoids against the 
aphids S chi z aphis g raminum and Myzus persicae have been 
demonstrated 35 • Many of these, including the dihydrochalcone 
phlorizin (12) and the flavanone eriodictyol (13) showed 
strong deterrency at concentrations well within the range 
often found in plants. Finally, the cotton leaf anthocyanin, 
cyanidin 3-glucoside (14) has been shown to be particularly 
inhibitory to the larval growth in the tobacco budworm 
Heliothis viriscens 36 . 
17 
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The oestrogenic activity of simple isoflavones such as 
daidzein (15) and of coumestans such as coumestrol (16) have 
long since been established and extensively discussed by 
McClure 32. These compounds are structurally related to the 







Although not as potent, they nevertheless approach sufficient 
levels in forage crops such as clovers (Trifolium spp.) and 
lucerne (Medico sativa) to exert definite physiological 
18 
effects when eaten in quanti ty 3 7 . In a review by Smolenski et 
al . 38 these phyto-oestrogens, as well as 
proanthocyanidins are featured among the toxic 
the 
and 
antinutrient compounds biosynthesised by leguminous plants. 
1 . 2 . 3. Pharmacology of the flavonoids 
In recent years interest in traditional remedies and plant 
derived drugs have witnessed a spectacular revival which is 
owed, perhaps in part, to improved methods of biochemistry 
and c l inical pharmacology. The flavonoids in particular, have 
received renewed interest. Their widespread occurrence in 
flowering plants, and therefore availability, as well as 
their overall uniformity in chemical structure, so that 
structure- activity relationships are 
makes this class of compounds ideal 
easily established, 
for pharmacological 
screening . It is therefore not surprising that a wide variety 








recent years. A thorough review of the 
activity of the flavonoids has recently been 
the editorship of Cody, Middleton and 
Harborne 39 • Some of the pharmacological activities displayed 
by the flavonoids are perhaps best illustrated with a few 
examples. 
An aqueous alcoholic extract of the root of a South American 
plant called "Cabeca de Negra" is available to plantation 
workers in the Amazon jungle as an oral antidote against 
snake and spider venoms. Two pterocarpans, cabenegrin A-I 
(18) and cabenegrin A-2 (19) were isolated as the active 
principles 4o . Both of these have been shown to possess potent 
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The anti-hepatoxic activity of the flavonoids has been 
reviewed by wagner 41 . Of these, a series of flavanolignans 
from S ilybum marianum which include silybin (20) and 
silymonin (21) have been shown to possess significant 
anti-hepatoxic activity 4 2 . 
HO 
MeO 
HO .... (]:O OCH3 HO .' 0 
0 
OH OH 
OH 0 OH 0 
(20) (21) 
Wagner points out that the discovery of these liver-active 
flavanolignans was not the result of systematic pharma-
cological screening but were derived from folk medicine. 
A number of flavonoids with anti-inflammatory properties have 
been isolated in recent years 43 . Of these, hypolaetin-8-
glucoside (22) isolated 44 from Sideritis mugronensis is 
interesting in that it displays both anti-inflammatory and 
anti-ulcer properties 45 . The authors suggest that this 
compound may provide a useful alternative to 







In the final example, a series of five dimeric, doubly linked 
flavonoids isolated from Ephedra spp.46-49, including 
structures (23) and (24) have been shown to possess 
significant coronary dilatory, or hypotensive properties. 
HO HO 
(23) (24) 
Recently, (23) together with related novel doubly linked 
proanthocyanidins have been isolated from Prunus spinosa so . 
Of particular interest is that this species is well known ln 
regions of Spain, where an infusion prepared from the bark is 
used in folk medicine for the treatment of hypertensionsl . 
1.3. THE PROANTHOCYANIDINS 
Of the various flavonoid classes the proanthocyanidins (syn. 
condensed tannins) are unique in their ability to exist as 
complex polymers. Their high molecular weight, and poly-
phenolic nature imparts to them the ability, amongst others, 
21 
to precipitate proteins such as gelatin from solution. This 
property (often called astringency ) is vividly illustrated by 
their use industrially in the tanning of animal hides to make 
leather. 
From a chemical point of view the proanthocyanidins have, 
until the last decade or so, remained largely unexplored . 
Technological advances in the field of chemical separation 
and identification, coupled with the recognition of the 
importance of the proanthocyanidins in herbal remedies, 
nutrition, and agriculture etc. has led to an unprecedented 
interest in this unique class of secondary metabolites. 
1.3 . 1 . Nomenclature 
In light of the recent dramatic increase in both the number 
and complexity of proanthocyanidins with novel structures, 
Porter s2 , in his review of the flavans and proanthocyanidins 
has proposed a nomenclature re-appraisal. He points out that 
Haslam's previous reviews s3 , s4 of the proanthocyanidins were 
confined to compounds based on a flavan-3 -01 skeleton and 
recommends that those compounds with an unsubstituted C-ring, 
the flavans, as well as the naturally occurring flavan-4-01s 
be included in the proanthocyanidin class of flavonoid. 
Following the earlier suggestions of Weinges and Freudenberg, 
Haslams 4 defined leucoanthocyanidins as monomeric proantho-
cyanidins, such as the phenolic flavan-3,4-diols, and 
condensed proanthocyanidins as flavan-3-01 dimers and higher 
oligomers . PorterS 2 suggests that this terminology be 
modified as follows: 
The term leucoanthocyanidin should include all monomeric 
flavanoids which produce anthocyanidins by cleavage of a C-O 
bond on heating with mineral acid, including not only the 
22 
flavan-3,4-diols, but also flavan-4-ols and unusual 
metabolites such as cyanomaclurin (25). Regarding proantho-
cyanidins, the term "condensed" should be dispensed and this 
group should be redefined to include all compounds which 
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OH 
(25) 
A recent system of nomenclature for naming proanthocyanidins 
was introduced by Hemingway et aI.55 and extended for general 
application by porter 52 , and is described as follows: 
i) Proanthocyanidins are named in a similar way to 
polysaccharides, where C-4 of the flavan monomer unit is (in 
the nomenclature sense) equivalent to C-l of the sugar unit 
in an oligo- or poly-saccharide chain. 
ii) The interflavanoid linkage is indicated in the same 
way as the linkage between sugar units; the bond and it's 
direction are contained in brackets. 
iii) The configuration of the interflavanoid bond at C-4 
is indicated by the (a,~) nomenclature 56 • 
iv) The flavanoid monomer units are defined in terms of 
the trivial names, for example, catechin, epicatechin, 
afzelechin, epiafzelechin etc. 
v) Flavanoid monomer units with the 28 configuration in 
the case of the flavan-3-ols and 2R configuration in the case 
of the flavans are distinguished by the enantio prefix, thus 
(+)-epicatechin becomes ent-epicatechin. 
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1.3.2. Structure and distribution 
A comprehensive register of the naturally occurring compounds 
in the flavan, flavan-3-ol, leucoanthocyanidin and proantho-
cyanidin (oligomeric and polymeric) classes, complete to 
1987, has been compiled by PorterS 2. The proanthocyanidins 
which occur widely in plants of a woody habit may be 
subdivided into two main groups, the singly linked B- type 
proanthocynidins and those containing a double interflavanoid 
linkage, the so called A-type proanthocyanidins. 
1.3.2.1. B-type proanthocyanidins 
Of the B- type proanthocyanidins the procyanidins, and in 
particular, the (4~8) linked dimers (B-1, B-2, B-3 and B-4) 
and their corresponding (4~6) linked analogues (B-S, B-6, B-7 
and B-8) have a widespread distribution. On the other hand, 
classes such as the propelargonidins are relatively uncommon 
in nature. 
A number of proanthocyanidins with a S-deoxy or resorcinol 
type A-ring, as opposed to the more commonly occurring 
phloroglucinol type A-ring have been isolated in recent years 
and include the proguibourtinidins, profisetinidins, 
prorobinetinidins and promelacacinidins. It is interesting to 
note that the vast majority of these compounds have been 
isolated from Acacia spp. The 5 (A) -deoxy-proanthocyanidins 
are often associated with structural features that are 
uncommon in proanthocyanidins with phloroglucinol A-rings, 
such as the enhanced tendency towards the biosynthesis of 
angular trimers and the common occurrence of 3,4-cis 
interflavanoid linkages. A typical example of such a compound 
is provided by the trimeric profisetinidin, 
fisetinidol-(4~~8)-catechin-(6~4a)-fisetinidol (26) isolated 













The highly successful semi-synthetic or biomimetic approach 
towards the synthesis of oligiomeric flavanoids, adopted by 
Ferreira and co-workers, has provided great insight into the 
rationalisation of the condensation sequences observed in 
these compounds . General principles which have emerged from 
their studies in this field of chemistry are authoritatively 
discussed in a recent review s8 • 
1.3.2.2 . A-type proanthocyanidins 
Since the first isolations9 and structure determination 6 0 , 61 
of proanthocyanidin A-2 (27 ) [epicatechin-(4~~8,2~~O~7)-
epicatechin], a variety of analogues possessing the doubly 
linked unit of either (2~,4~)- (27) or (2a,4a)-configuration 
(28) have been reported 46 - SO , 62, 63 , 64 , . However, in contrast 
to the wide distribution of B-type proanthocyanidins those of 
the A-type are relatively rare and occur in a restricted 
number of plant species . 
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(30) R=O-L-Ara . 
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Although the majority of these fall into the procyanidin 
class of condensed tannins, constituent units other than 
those based on the catechins have been isolated, and include 
a flavonol 46 , a flavan 47 , epigallocatechin 65 and the 
afzelechins 48 , 49 , so , 66. Of the three possible linkage isomers 
viz. (4~6,2~O~7), (4~6,2~O~5) and (4 ~8,2~O~7) the latter mode 
of linkage is by far the most prevalent. The sole example of 
a (4~6,2~O~7) linkage is provided by mahuannin C (31) 
[epiafzelechin-(4~~6,2~~O~7)-epiafzelechin] isolated from 
Ephedra spp49. Recently epicatechin-(4~~6,2~~O~5)-epicatechin 
(32) has been reported 64 as a new natural product from 
Theobroma cacao and is the only example with the (4 ~6,2~O~5) 
mode of linkage. 
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Interestingly, two A-type proanthocyanidin glycosides, 
ent-epicatechin-3-0-D-galactopyranosyl-(4a~8,2a~O~7)­
epicatechin (29) and ent-epicatechin-3-0-L-arabinopyranosyl-
(4a~8, 2a~O~7) -epicatechin (30) have been isolated from the 
same source . These, together with epigallocatechin-
(4~~8/2~~O~7)-epigallocatechin-3-0-gallate, isolated 65 from 
commercial oolong tea, are presumably the only known 
substituted A-type proanthocyanidins. A number of procyanidin 
oligomers containing both A- and B-type linkages have been 
isolated 67 , 68 , 69. Of these, a series including a trimer, two 
tetramers, including (33), and a pentamer isolated 69 from 



















Structure elucidation was based largely on partial acid-
catalysed degradation of these compounds with phenyl-
methanethiol, in conjunction with 1H_ and 13C-NMR analysis . 
Owing to the close structural relationship between proantho-
cyanidins of the B- and A-type, Porter 52 has proposed that 
the A-type proanthocyanidins are formed from their 
corresponding B-type proanthocyanidins via an enzyme mediated 
hydroxylation at C-2(C), in much the same way as the 
auto-oxidation at C-2(C) in the chemical conversion of 
procyanidins to cyanidins 70 . 
The conversion of B- to A-type proanthocyanidins under mildly 
basic conditions has recently been demonstrated by Ferreira 
and co-workers 71 , 7 2 . These authors propose that the 
transformation of, for example, procyanidin B-2 (34), into 
the corresponding A-type proanthocyanidin (27) involves the 
oxidative removal of a hydride ion at C-2(C) as the initial 
step. They suggest that although trace amounts of oxygen may 
effect the transformation of (34) to (35), it seems more 
reasonable that the prevailing conditions induce oxidation of 
the o-dihydroxy functionality of the pyrocatechol B- or 
28 
E-rings to an o-quinone which subsequently serves as oxidant 
for the conversion of (35) to (27) shown below. 
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2 . 1 . OVERVIEW 
The initial objective of this study was to isolate and 
characterise biologically active compounds from Cassipourea 
g errardi i (RHIZOPHORACEAE). The bark from this indigenous 
South African species is well known in the local herbal 
medicine trade, where it is known as "memezi obomvu". The 
ground bark is used, mainly by Zulu women, in the form of a 
face pack in this fashion it is reported to have skin 
whitening properties . Demand for this product, which is 
estimated at over eight tonnes per annum, has resulted in a 
serious decline in the wild population of this species 73 . 
In light of the increasing vulnerability of this species and 
since previous chemical studies 5 were confined to the 
alkaloid constituents, a re-investigation was warranted in 
order to gain a more comprehensive knowledge of the chemical 
constituents of this species. 
TLC analysis of the extractives of the stem bark from C . 
gerrardii revealed, upon staining with diazotised benzidine 
reagent, a phenolic rich fraction . Using a combination of 
chromatographic techniques, a series of compounds belonging 
to the proanthocyanidin class 
These include the known 
(37 ) and 
of flavonoids were isolated. 




(38) as well as three novel compounds 
afzelechin-3-0-a-L-rhamnopyranoside 74 (39), 
epiafzelechin-(4~~8,2~~O~7)-ent-afzelechin7s (40) and 
epiafzelechin-(4~~6)-epiafzelechin-(4~~8,2~~O~7)-ent­
afzelechin (41). In contrast to the naturally occurring 
catechin and gallocatechin derivatives afzelechin derivatives 
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(40) (41) 
As a result of these findings this work was extended to 
include a similar study of two related species viz. C . 
gummiflua and C . mossambicensis. 
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As was the case with C. gerrardii, previous chemical studies 
on C . gummiflua were restricted to the isolation of alkaloid 
constituents 4 . Using a similar strategy to that developed for 
the phenolic constituents in C . gerrardi i, eight compounds 
were isolated. Of these (36), (37), (38), (39), and (40) 
were found to occur in C. gerrardii. Two new compounds were 
7-0Me-epiafzelechin-also isolated and identified as 
(4~~8,2~~O~7)-ent-afzelechin 
(4~~8,2~~O~7)-epiafzelechin 





A flavonol glycoside was 














Stem bark from c . mossambicensis, a hitherto unstudied 
species, yielded besides (36), (37), (38), (39), (40) and 
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The distribution of compounds isolated from Cassipourea 
species during the course of this work is summarised in Table 
1 . . 
Table 1. Distribution of compounds isolated from 
Cassipourea spp . 
Compound C. gerrardii C. gummiflua C. mossambicensis 
(36) x x x 
(37) x x x 
(38) x x x 
(39) x x x 
(40) x x x 
(41) x - x 
(42) - x -
(43) - x -
(44) - x -
(45) - - x 
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A concise botanical description of these species, including 
their distribution in Southern Africa has been published 3 . It 
is interesting to note that members of the Rhizophoraceae 
family have, for many years, been used in the tanning 
industry 7 6. The present isolation of "tannins", or more 
specifically, proanthocyanidins from Cas s ipourea species is 
therefore not surprising . 
2.2. EXTRACTION AND ISOLATION 
Owing to the close similarity of the phenolic profiles 
encountered in the Cassipourea species studied, the 
extraction and isolation strategies developed for the 
isolation of compounds from C . gerrardii were easily extended 
to both C . gummiflua and C . mossambicensis. These strategies 
are discussed in this section . A characteristic feature of 
the phenolic extractives of these species was the occurrence 
of a large number of diastereomeric pairs. The separation of 
these diastereomers proved to be particularly challenging, 
although reasonable success was achieved with HPLC and HSCCC 
methods. HSCCC is a relatively recent development in the 
field of chromatography and thus the practical merits of this 
technique will be discussed. 
The solvents most commonly employed for the extraction of 
phenolic compounds are EtOH (95%), MeOH and aqueous acetone 
(60-80%) . Preliminary extractions on small quantities of bark 
revealed that acetone (60%) was the most effective solvent, 
but was judged unsuitable owing to the difficulty associated 
with reducing the aqueous fraction to workable volumes after 
extraction. EtOH (95%) was chosen as a suitable alternative . 
Following exhaustive extraction (Soxhlet) of the air dried 
and powdered stem bark, the extractives were concentrated 
under reduced pressure, suspended in water, and in the case 
of C . gerrardii this was followed by successive extractions 
with hexane, CHC1 3 and EtOAc . A similar procedure was adopted 
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with the extractives from C . g ummiflua and C. mossambicen sis 
except that the step involving extraction with hexane was 
omitted. 
TLC analysis of these fractions revealed upon staining with 
suitable reagents (diazotised benzidine and anisaldehyde 
reagent) that the phenolic compounds were restricted 
exclusively to the EtOAc fractions. TLC analysis of the EtOAc 
extractives from C. gerrardii, C. 
mossambicensis are shown (Plate 1.) 
g ummiflua and 
- ( 43 ) 
- ( 42 ) 
_ ( 36 ) and (37) 
-(38 ) 
- ( 40 ) 
_(45) 
- ( 44 ) 
- (3 9 ) and ( 41 ) 
C . 
Plate 1. (Xl) TLC chromatogram of the EtOAc extractives from C. gerrardii 
(A) , C. gummiflua (B) and C. mo ssambi censis (C) . Compound numbers 




-MeOH ( 39 : 60 :1) 
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For silica gel based separations (CHCI 3 or CH 2 CI 2 )-acetone-
MeOH proved to be a useful solvent system. By varying the 
solvent ratios between (70 : 30:0) and (39:60:1) suitable Rf 
values, and separations devoid of tailing could be obtained 
for any of the desired phenolic compounds . The solvent system 
was extremely useful in that gradient elutions could easily 
be performed simply by increasing the ratio of acetone in the 
system in stepwise increments. At higher solvent polarity 
(acetone content > 50%) the addition of MeOH served to 
prevent tailing . A direct attempt to purify the crude EtOAc 
extract from C . g errardi i on silica gel by column 
chromatography, however, proved to be unsuitable due to the 
similar Rf values of many of these compounds. 
A solution to this problem proved to be reverse phase column 
chromatography over Sephadex LH-20 . Trial separations using 
EtOH (95%) as eluent demonstrated that monomeric flavan-3-ols 
and their glycosides were eluted first, followed by the 
dimers and trimers. A surprising feature of these separations 
was the high degree of plant material irreversibly adsorbed 
to the column and which resulted in rapid deterioration of 
the Sephadex LH-20. It was found that an initial crude 
fractionation of the phenolic plant material on silica gel by 
column chromatography using CHCl 3 -acetone (2 : 3) as eluent 
prevented this occurrence and also served to remove less polar 
non-phenolic contaminants. This procedure was also adopted 
with the phenolic fractions from C . gummiflua and C. 
mossambicensis except for the following modifications : 
i) Better fractionation was achieved on the silica gel 
"pre - columm" using a gradient elution with the solvent system 
previously described . 
ii) The solvent system for the Sephadex LH-20 
Using aqueous MeOH and increasing 
(50:50) to (100 : 0) in stepwise 
separations was changed. 
the MeOH-H 20 ratios from 
increments, better control of the separations was achieved. 
This resulted in complete separation between the monomeric 
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and dimeric compounds. 
Subsequent purification of these fractions over silica gel 
(Flash and centrifugal thin layer chromatography) afforded 
the phenolic compounds either in pure form, or in the case of 
the diastereomers, as diastereomeric mixtures. 
The question arose as to whether these diastereomeric pairs 
were produced in vivo, or whether one of the diastereomers 
within each pair was an artifact, produced via epimerization 
either during the period that the bark was drying or during 
the extraction process. The logical solution was to rapidly 
extract a small piece of fresh bark, under mild conditions, 
followed by immediate TLC analysis. In general TLC analysis 
of crude extractives seldom provides good results. Resolution 
is generally poor presumably due to the large number and 
vastly differing polarities of compounds usually encountered 
in these extracts. The concentration of individual components 
within such mixtures is usually low, hence the problem 
associated with the visualization of these compounds on the 
chromatogram. The following simple method was devised which 
solved some of these problems and may serve as a generally 
useful method for the rapid screening of plant phenolics: 
A small quantity of fresh bark (ca. 19) was macerated and 
vigorously shaken for a few secs in a test tube half filled 
with aqueous acetone (60%). Saturation of the mixture with 
NaCI resulted in a phase separation. The upper 
(acetone) was immediately subj ected to TLC analysis. 
staining with diazotised benzidine reagent, 







thus verifying their biosynthetic 
The separation of the diastereomers within each 
diastereomeric pair proved to be particularly challenging. 
Although these separations could be detected on TLC, it is 
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surprising that they could not be effected on a preparative 
scale with silica gel, either by centrifugal or preparative 
TLC. In both methods the diastereomers within each pair 
travelled as unresolved bands, even at low sample 
concentrations. Partial success was achieved with reverse 
phase column chromatography over Toyopearl HW-40F. A mixture 
of (38) and (40) from C. gerrardii was subjected to repeated 
chromatography over Toyopearl HW-40F with EtOH (BO%) as 
eluent. In this way pure fractions of the major diastereomer 
(40) were obtained. The minor diastereomer (38) could only be 
obtained in an enriched form due to tailing of (40). An 
attempted final purification of the trimer (41) resulted in 
extremely poor recovery, presumably due to decomposition on 
the column. Owing to the apparent harshness of the columm 
conditions, further separations using this method were 
avoided . 
HPLC proved to be a useful tool for the separation of 
diastereomers . Small quantities of (36) and (37) were 
separated on a semi-preparative C-IB reverse phase columm 
with solvent programming . Complete separation of (38) and 
(40) was also achieved by HPLC using a C-IB preparative 
columm with H20-MeOH (60:40) as eluent. The methylated dimers 
(42) and (43) could not, however, be separated on the C-IB 
columm largely due to the insolubility of these compounds in 
aqueous solvent systems. 
Countercurrent chromatography (CCC) designates a family of 
liquid-liquid partition chromatographic methods which do not 
employ a solid supporting matrix. As a result, these methods 
benefit from a number of advantages over liquid 
chromatography: there is total recovery of the introduced 
sample and no irreversible adsorption on a solid matrix, 
tailing is minimised, denaturation of sample is minimal and 
solvent consumption is low. 
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High-speed countercurrent chromatography (HSCCC) is a 
relatively recent development in this field. Unlike droplet 
countercurrent chromatography (DCCC) which relies on gravity 
for the retention of stationary phase, HSCCC relies on 
centrifugal force to retain the stationary phase. 
Consequently, the mobile phase can be pumped at much higher 
flow rates, thus allowing much faster separation times. Both 
DCCC and centrifugal partition chromatography (CPC) have been 
discussed in a recent review 77 • Separation of the 
diastereomers (38) and (40) as well as the diastereomers (42) 
and (43) was achieved by HSCCC with a P.C . Inc. Multilayer 
Coil Planet CCC instrument. 
Briefly I the separation column consists of a Teflon tube 
( i . d. 2 . 6mm volume ca. 400ml) wrapped as a coil around a 
spool. The coil is balanced by a counter-weight and describes 
a planetary motion about a central axis 78 (Fig. 2.). 
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Fig. 2. Schematic diagram of the MLCCC instrument . 
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technique, the motion of the coil generates a train of 
dynamic mixing zones . This repetitive mixing and settling 
process, ideal for solute partitioning, occurs at over 13 
times per second 7 9 • 
The procedure for loading the instrument 8 0 consists first of 
pumping stationary phase into the stationary coil and then 
introducing mobile phase, after commencing rotation . When the 
necessary stationary phase has been displaced and mobile 
phase alone leaves the coil , the sample is introduced via a 
loop. Sample volumes between 10 and 30ml are recommended . 
Furthermore, since the sample may be introduced in either the 
mobile or stationary phase or a mixture of the two phases 
sample solubility seldom presents a problem. 
For successful separations the choice of the two-phase 
solvent system is critical. Unlike DCCC which is limited to 
solvents which form droplets the centrifugal apparatus can 
accommodate a broader variety of solvent systems, ranging in 
polarity from hexane-H 20, EtOAc-H 20, I-butanol-H 20 and 
2-butanol-H 20. The solute partitioning coefficient can be 
systematically shifted by varying the content of a third or 
fourth component. Either phase may be chosen as the mobile 
phase . For good retention of the stationary phase rapid 
partitioning of the phases is a pre-requisite. 
EtOAc-H 20-MeOH-hexane proved to be a useful solvent system 
for the separation of the diastereomers (38) and (40) as well 
as the diastereomers (42) and (43). Partitioning of solutes 
into the organic layer is usually favoured by increasing the 
EtOAc content, while transfer to the aqueous phase is 
promoted by adding MeOH. In this way suitable partition 
coefficients 81 (ca. K = 1) may be obtained for compounds over 
a wide polarity range. For each diastereomeric pair, solvent 
ratios were varied until a relatively even distribution of 
these compounds was observed in the upper and lower solvent 
phases as judged by TLC. Separation of these diastereomers 
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proved to be extremely sensitive to the solvent composition. 
Good separations with the upper phase as the mobile phase 
were only achieved after a fair degree of "trial and error". 
A far better method involved the employment of a gradient 
elution for the separation of these compounds . This method 
allowed greater flexibility without the need for the 
relatively precise mixing ratios required when using an 
isocratic elution system. Using the solvent system 
H20-EtOAc-hexane-MeOH (30:48:24:21), with the upper phase as 
the mobile phase, and increasing the polarity of this phase 
in a linear fashion with water saturated EtOAc (Fig. 3.) 
separation of all four compounds was readily achieved . 
rr===== -. P u mp - --HSCCC 
S OOml H2 0 sat . EtOA c 
~St i rrer b ar .... ... -==--
SOOml Mob i le phase 
( upper layer ) 
Fig. 3. Gradient elution system . 
A solvent flow rate of 60ml/h and sample loads of between 350 
and 450mg was achieved . Increasing any of these parameters 
resul ted in poor retention of the stationary phase. 
Separation times were relatively 
hours for compounds (42) and 
compounds (38) and (40). 
slow, varying 
(43) and 12 . 5 
between 8 
hours for 
Solvent flow rate and sample loading is dependent to a large 
degree on the composition of the solvent system . It is 
however worth noting that solvent flow rates of 240ml/h and 
sample loads of up to 2g are possible 77. Good resolution, 
simple operation and low solvent consumption makes HSCCC a 
versatile technique for the separation of natural products. 
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2.3. STRUCTURAL ELUCIDATION 
2.3.1. Afzelechin and epiafzelechin 
Compounds (36) and (37) were both isolated as pale yellow 
crystalline solids and identified as afzelechin 82 (36) and 
epiafzelechin 83 (37) respectively, by comparison of their 
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Both afzelechin and epiafzelechin were isolated from the stem 
bark of C . gerrardii (0.0016% and 0.0016% respectively), C . 
gummiflua [0.006% and (0.001% detected via lHNMR, but not 
isolated) respectively] and c . mossambicensis (0.003% and 
0.008% respectively) . 
Most of the compounds isolated during the course of this work 
are based on a 5,7,4'-flavan-3-ol nucleus, thus (36) and (37) 
serve as useful model compounds. It is therefore appropriate 
to discuss the conformation of the flavan heterocycle in 
these type of compounds I and to compare I briefly I the 13C_ 
and lH-NMR spectra of (36) and (37). 
2.3.1.1. Conformation of the flavan heterocycle 
The preferred conformation of flavan derivatives in which the 
heterocyclic ring approximates a half chair conformation, 
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with the B-ring in a quasi-equatorial position has been 
discussed by Clarke-Lewis 8 4 • More recently, definitive 
evidence of the shape of the flavan-3 - ol ring system has come 
from X-ray analysis of 8-bromo-5,7,3' ,4'-tetra-OMe-catechin 8 5 
(46), 8-bromo-5,7,3' ,4'-tetra-OMe-epicatechin54 (47) and 
epicatechin 86 (48). 
((OMe OCOH Br ,\\~: I '\\\: I MeO HO 
.' OMe .' OH 
R2 OH R2 
OMe 
(46) R1=H; R2=OH (48) R1 =OH; R2=H 
(47) R1=OH ; R2=H (49) R1 =H; R2=OH 
Based on combined X-ray, crystallographic, molecular 
mechanical (MM2) and variable temperature I HNMR studies of 
(48) and (49) and their derivatives Porter, Mattice and 
co-workers 8 7 have shown that the C-ring conformation may be 
described in terms of the C-ring equilibrium: 















C(3) - sofa 
E-conformers A-conformers 
where E- and A-conformers are those 
equatorial or axial respectively. Fig. 
ground-state energy conformations that may 
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with the B-ring 
4. depicts the 
be adopted by the 
flavan heterocycle . The conformations are viewed along the 
plane indicated by the arrow. 
C (2) 
~ 
C ( 3 ) C ( 3 ) 
C(2)-sofa Half chair C(3) - sofa 
Fig. 4. Ground-state energy conformations adopted by the flavan heterocycle . 
The conversion of E- to A-conformers, or vice versa proceeds 
via the boat conformation which is the high energy transition 
state. An unequal conformational energy for the E- and 
A-conformers is manifested by an unequal popUlation of the 
two states, the one with the lower energy being populated to 
a greater extent . 
Using low temperature lHNMR 
exchange was demonstrated 
epicatechin (48 ) with E:A 
spectroscopy, conformational 
in both catechin (49) and 
ratios of 62:38 and 86:14 
respectively87. Acetylation of the 3-hydroxy group of 
catechin altered the ratio to 48:52, thus favouring the 
A-conformation. 
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In both (48) and (49) substitution at C(4) by a hydroxy or 
aryl substituent strongly favoured the E-conformation. This 
was explained by a balance between strain energies arising 
from l,2-repulsions, l,3-diaxial interactions, and the 
pseudo-allylic effect 88 • It was concluded that the preferred 
conformers of catechin-4 and epicatechin-4 units would adopt 
the C(2)-sofa and the half-chair ground state energy 
conformations respectively. 
2.3.1.2. NMR spectra of afzelechin and epiafzelechin 
The diastereomers afzelechin and epiafzelechin differ in 
their stereochemistry at the C(3) stereocenter. As expected 
the lHNMR spectra of (36) and (37) are similar, differing 
mainly in the coupling constants of the C-ring proton 
resonances (Table 2.) . 
Table 2. lHNMR (200MHz) spectral data for compounds (36) and (37) 
in [(CD3)2CO]. 
H 36 37 
2(C) 4.59 d (7.69) 4.92 br s 
3(C) 4.04 m 4. 193 m 
4(C) ax 2.94 dd (5.27, 16.02) 2.88 dd (4.33, 16.74) 
4(C) eq 2.53 dd (8.48, 16.02) 2.73 dd (3.ll , 16.74) 
6(A) 5.87 d (2.31) 5.91 d (2.31) 
8(A) 6.02 d (2.31) 6.01 d (2.31) 
2',6'(B) 7. 25 d (8.70) 7.35 d (8.73) 
3',5'(B) 6.83 d (8.70) 6.80 d (8.73) 
In the lHNMR spectra of flavan-3-ols and the polymeric B-type 
proanthocyanidins the signal due to the proton at position 2 
on the heterocycle is of particular diagnostic value. A large 
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coupling constant (J 2, 3 ca. 7-9Hz) indicates a 2,3-trans 
stereochemistry, while a small coupling constant (J 2, 3 ca. 
1Hz) indicates a 2,3 - cis stereochemistry. 
An interesting observation may be made concerning the lHNMR 
spectra of (36) and (37). Besides the obvious difference in 
the signals arising from the C- ring protons, the H-2' ,6' (B) 
proton signals of (36) are upfield (0-0.10) relative to the 







interaction between these protons and the 
This observation is confirmed by Dreiding 
serve as a method for determining the 
2,3-relative stereochemistry 
proanthocyanidins (see later) . 
of the upper unit in A-type 
2 . 3.1 . 3. Relative vs . absolute stereochemistry 
A number of flavan-3-0Is with the 28 or so called 
ent-configuration have been isolated . This enantiomerism is 
not restricted to the flavan-3-0Is . A number of 
proanthocyanidins of the B-type, and in particular those of 
the A- type, have been isolated containing one or more units 
with the ent-configuration. It is therefore clear that, 
although the coupling constants provide useful information 
concerning the relative stereochemistry, they are no longer 
acceptable as being indicative of the absolute 
stereochemistry in these compounds. 
The proposal by Ellis 89 , that proanthocyanidins with the 28 
stereochemistry arise from their 2R counterparts by the 
action of a C-2 epimerase enzyme seems plausible, 
particularly if one considers that in cases where 
proanthocyanidins with the 28 configuration have been 
isolated, the corresponding 2R isomers generally CO-occur . 
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2 . 3.2 . 4' OMe epigallocatechin 
Compound (45) was isolated from the stem bark of C. 











The 13 C_ and 1H- NMR spectra of (45) were similar to those 
recorded in the literature for epigallocatechin 9 0 (50), the 
significant differences being the inclusion of a 3H singlet 
at 83.821 in the 1HNMR spectrum and an additional 13 CNMR 










The HETCOR spectrum of (45) showed strong coupling between 
these signals. The chemical shift of these signals are 
characteristic of a methoxy group and it was thus logically 
inferred that (45) was an O-methylated epigallocatechin . 
These observations are supported by the positive FAB mass 
spectrum which displayed a [M+H] + ion at m/z 321. The methoxy 
group was established to be located at position 4' (B) based 
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on the downfield shift of C-4' (B) (0+3 . 18) in (45) relative 
to the same signal in (50) . This was confirmed by the DELAYED 
HETCOR (10Hz) spectrum, which displayed weak, but distinct 
coupling between the methoxy protons and C-4' . 
4'-OMe-epigallocatechin was origionally isolated from the 
root of Ouratea sp . 91 and given the trivial name 
Ourateacatechin . This compound has subsequently been isolated 
from the root bark of further species in the 
Celastracea 92 , 9 3 , 94. 
Comparison of physical and spectral data of (45) with that 
recorded in the literature serves to confirm the proposed 
structure. The isolation of (45) from C . mossambicensi s is 
significant in that its occurrence has hitherto been 
restricted to species in the Celastracea . 
2 . 3.3 . Afzelechin-3-0-a-L-rhamnopyranoside 
The novel flavan-3-ol glycoside (39) was isolated as a 
semi-crystalline hygroscopic solid from c . gummiflua 
(0.023%), C . gerrardii (0.0007%) and C . mossambicensis 
(0.030%) . Its structure has been established from 
spectroscopic and hydrolytic 
afzelechin-3-0-a-L-rhamnopyranoside 74 . 
crOR \" ROW'" .....::: ,.. " 
~I 
o 
OR L ~OR 
"~OR 
OR CH3 
(39) R = H 
(39a) R = Ac 
studies as 
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The IH-NMR and 13C-NMR spectra of (39) recorded in acetone-d 6 
clearly revealed the presence of a 5,7,4' - trihydroxy 
flavan-3-ol nucleus . Furthermore, the proton coupling 
constant of H-2(C) (84.74, d , J=7 . 85) was consistent with a 
2,3-trans relative stereochemistry . The remaining 13C- and 
IH-NMR signals, together with the positive FAB mass spectrum 
which displayed an [M+H] + ion at m/z 421, suggested the 
presence of a carbohydrate moiety of the methyl pentose type. 
Analysis of the IHNMR spectrum following D2 0 exchange, in 
conjunction with the COSY spectrum enabled IH_IH correlations 
and coupling constants of the remaining proton signals to be 
established as follows: 
~o 
H 
H83 . 65 
83.73H 
J 1 " • 2" =1. 57Hz 
J 2 " • 3 " =3 . 35Hz 
J 3 " • 4 " =9. 44Hz 
J 4 " • 5 " =9 . 44Hz 
J 5 " • 6 " =6 . 20Hz 
Comparison of these results, together with the chemical shift 
positions of the remaining carbons with those recorded in the 
literature for the structurally closely related compound, 
catechin-3 - 0-a-L-rhamnopyranoside (51) isolated from Quercus 
miyagii
95 confirms the rhamnose moiety. 
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OH L ~OH 
"d~OH 
OH CH 3 
( 51) 
It has been reported that the configuration at the anomeric 
carbon centres of rhamnose may be assigned on the basis of 
the J H- l " coupling constant 9 5 . Based on an examination of the 
Dreiding models for both the a- and ~- anomer it would appear 
that the dihedral angle between H-l" and H-2" in both anomers 
is very similar (ca, 550) and should thus lead to almost 
identical coupling constants for these protons. The 
a-configuration was thus assigned to the glycosidic linkage 
based on the chemical shift of C-3" and C-5" of rhamnose, in 
which the signals due to the a-anomer (872.5 and 69.4 
respectively) resonate at higher field than those in the 
~-anomer (875 . 4 and 73.5) 96 , 9 7. 
The location of the rhamnose moiety was judged to be at C-3 
based on the downfield shift of this resonance (8+6.58) 
relative to the same signal in afzelechin (36). Enzymic 
hydrolysis with hesperidinase afforded the aglycone which was 
confirmed to be afzelechin by comparison with an authentic 
sample . 
Acetylation of (39) gave a hexa-acetate (39a) which was also 
fully characterised and which serves to confirm the structure 
of (39) as afzelechin-3-0-a-L-rhamnopyranoside. Although 
flavan-3-ols are widely distributed in nature their 
glycosides are rarely found. It has been suggested 52 that 
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their apparent scarcity may be due to incorrect techniques 
used for their isolation. Although (39) gave a positive 
colour reaction with both anisaldehyde and benzidine 
reagents, it did not stain as intensely as either the 
flavan-3 - o1 monomers (36) and (37), or the flavonol glycoside 
(44) and consequently was almost overlooked. If this relative 
insensitivity towards these commonly used stain reagents is 
displayed by the flavan-3-o1 glycosides in general, it might 
further explain their apparent scarcity . 
The following interesting observations could be made from a 
study of the delayed IH- IH COSY spectrum of (39) using 
a coupling constant of 5Hz : 
i) Weak, but quite distinct coupling between the 
phenolic proton signals on C-5 and C-7 while that from C-4' 
shows no coupling . This allows accurate "labelling" of the 
position of the phenolic protons. 
ii) Distinct coupling between the signals from the C- 4' 
hydroxyl group and the signals from 2',6' (but not 3',5') 
protons and between C-7 hydroxyl and H-6 and H-8 . 
iii) Very strong couplings between the signals from 
H-2' ,6' and H-2 and slightly weaker couplings between H-3' ,5' 
and H-2. 
iv) Strong coupling between the signals from H-8 to H-4 
and the corresponding coupling between H-6 and H-4. 
These long range couplings served to confirm the proposed 
structure as well as providing a generally applicable method 
for establishing the relationship between protons separated 
by more than one bond . 
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2.3.4. Kaempferol-3 O-a-L-rhamnopyranoside 
The flavonol glycoside (44) was isolated from the stem bark 
of c. gummiflua (0 . 026%) as a pale yellow amorphous powder 




OR 0 ~ OR 
°OR CH 3 
(44) R = H 
(44a) R = Ac 
In the phenolic region of the IHNMR spectra of (44) , the 
5,7,4'-trihydroxy substitution pattern is clearly 
discernible. The remaining proton signals, incl uding the 
characteristic anomeric proton resonance at (65,41, d, 
J=1. 74Hz) and the methyl resonance at (60.96, d, J=5. 79Hz) 
clearly suggests the presence of a methyl pentose glycoside. 
From the 13CNMR spectrum of (44), and based on the presence 
of a carbonyl resonance at 6179.45 together with the olefinic 
resonances at 6159.13 and 6136.13 it was logically inferred 
that the aglycone was a flavonol. The positive FAB mass 
spectrum of (44) showed a [M+H] + peak at m/z 434 consistent 
with a molecular formula C21H20010. Comparison of the 13CNMR 
data of (44) with that published 98 for kaempferol (52) , 
kaempferol-3-0-~-D-glucoside (53) , myricetin-3-0-a-L-rham-
nopyranoside (54) and quercetin-3 - 0-a-L-rhamnopyranoside 





(53) Rl=R2=H; R3=glucose 
(54) R1 =R 2=OH; R3=rhamnose 
(55) R1 =OH; R2=H; R3=rhamnose 
52 
The 13CNMR shifts of the carbons on the sugar moiety are in 
close agreement with the corresponding signals of the 
flavonol rhamnosides (54) and (55). Comparison with both 
(52)and (53) leaves no doubt that the aglycone is kaempferol. 
Furthermore, the downfield shift of C-2 (8 +12.33) in (44) 
relative to the same signal in (52) is consistent with 
glycosidation at C-3. 
Al though biogenetically closely related to the flavan- 3 -01 
glycosides, flavonol glycosides, unlike the flavan-3-ol 
glycosides have a widespread distribution in the plant 
kingdom. The isolation of kaempferol-3-0-a-L-rhamnopyranoside 
has been reported from a number of plant sources and 
comparison of physical and spectral data of (44) and the 
hexa-acetate derivative (44a) to that recorded in the 
literature 99 serves to confirm the proposed structure. 
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2.3.5. Epiafzelechin-(48~8,28~0~7)-epiafzelechin 
The A- type proanthocyanidin dimer (38) was isolated from the 
stem bark of C. gerrardii (0,036%), C. gummiflua (0.045%) and 
C. mossambicensis (0.109%) and identified as epiafzelechin-
(4~~8,2~~0~7)-epiafzelechin . 
The positive 
[M+H] + ion 
diazomethane 
(38) Rl =R2=H 
(38a) R1=Me ; R2 =H 
(38b) R1 =Me ; R2=Ac 
FAB mass spectrum of compound (38) displayed an 
at m/z 545. Upon methylation with ethereal 
compound (38) yielded a pentamethyl ether (38a) 
which was acetylated with acetic anhydride in pyridine to 
afford the pentamethyl ether di-acetate (38b). It was thus 
inferred that (38) had, as part of it's structure, five 
phenolic and two alcoholic hydroxyl groups . 
Analysis of the lHNMR spectrum of (38) revealed, at lowest 
field in the aromatic region of the spectrum, a pair of A2B2 
spin systems. The chemical shifts and coupling constants of 
these signals were similar to those for the B-ring proton 
signals of epiafzelechin (37). The chemical shifts and 
coupling constants of several other signals in the lHNMR 
spectrum were also similar to 
epiafzelechin. Of these, a pair of 
(06.05 and 6.11, both J=2.6Hz) were 
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those recorded for 
meta-coupled doublets 
similar to the A-ring 
signals for epiafzelechin and three signals in the aliphatic 
region of the spectrum at 05.0, 4.1 and 2.9 closely matched 
the C-ring signals of epiafzelechin. A 1H singlet at 06.13 
suggested the presence of a penta-substituted benzene with 
oxygen functions at the 1,3,5 -positions. These observations 
implied that (38) comprised of two 5,7,4'-trihydroxy-
flavan-3-ol units. The remaining proton signals, present as a 
pair of 1H doublets (J= 3.5Hz) at 04.10 and 04.46 together 
with the 13CNMR resonances at 029.25 and ketal resonance at 
0100.26 indicate that the flavan-3-o1 units are joined via a 
C-4(C) carbon-carbon linkage and a C-2(C) ether linkage. The 
characteristic coupling constants and chemical shifts of 
these signals are generally regarded as being of diagnostic 
value for establishing the presence of A-type linkages in 
these type of compounds 5 ° , 67,71. 
Three types of linkage isomers are possible viz . (4-+6,2-+0-+7) 





(56) ( 57) 
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Selection of the mode of linkage could not be determined with 
any certainty from a study of the 1 3C_ and IH-NMR spectra of 
(38) . The IHNMR spectrum of the pentamethyl ether derivative 
(38a) showed, together with four methoxy signals between 
83 . 72 and 3.82, one upfield methoxy signal at 83.49. The 
I H- IH COSY spectrum of (38a) displayed weak, but distinct 
coupling between the high field methoxy proton signal and 
H-6 (A) . These results established the methoxy group to be 
located at position 5(A). This unusual upfield shift may be 
interpreted in terms of a through space interaction with the 
lower structural unit and is only possible in the (4~8 , 2 ~0~7) 
mode of linkage represented by (38). 
The absolute stereochemistry at C-4 (C) for (38 ) was 
established from the sign of the Cotton effect at ca . 
200-220nm on the basis of the report 100 , that such compounds 
having 4R configurations exhibit a positive couplet and those 
with 4S configurations a negative couplet in this wavelength 
region. Circular dichroism measurements in EtOH revealed a 
negative Cotton effect at 271nm ([8]=-16.6 X 10 3) and a 
positive Cotton effect at 222nm ([8]=71.9 X 10 3), thus 
indicating a 4R configuration. The configuration at C-2(C) is 
thus automatically assigned. The 3R configuration was 
tentatively assigned to C-3(C) based on the observation that 
the proton resonance for H- 2',6' (B) (87.53, J=8.8Hz) matched 
closely with the corresponding signal for epiafzelechin (37) 
( 87 . 4, J = 8 . 7Hz) . 
Following a literature search on A-type proanthocyanidins 
compound (38) was found to be identical to mahuannin B , 
previously isolated from the roots of Ephedra sp . 48 . These 
workers determined the absolute stereochemistry of mahuannin 
B by application of NMR and CD spectroscopy. They also 
confirmed the absolute stereochemistry at the C-3 positions 
by esterification of the pentamethyl ether derivative (38a) 
with (±)-2-phenylbutanoic acid by application of the Horeau 
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Brooks method. 
No data for the derivative (38a) and only partial data for 
the derivative (38b) was reported 48 . Both these derivatives 
have now been fully characterised . It is interesting to note 
that the signal due to H-3(C) in the IHNMR spectrum of the 
pentamethyl ether derivative (38a) is unusual. Instead of 
appearing as a "characteristic" doublet (J=3.5-4.0Hz), 
additional coupling is observed (04.717, dd , J=3.44, 5.94Hz). 
The1H-lH COSY spectrum clearly reveals that this additional 
coupling is due to OH-3 (C) (01. 941, d , J=5. 94Hz) . 
In general, the IH-IH COSY spectra, often in conjunction with 
the DELAYED IH_IH COSY spectra, proved extremely useful for 
the accurate assignment of the IHNMR signals in the spectra 
of the A-type dimers and their derivatives. 
2.3 . 6 . Epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin 
The novel A-type proanthocyanidin 7 s (40) was isolated as a 
pale yellow amorphous powder from the stem bark C . gummiflua 
(0.105%), C . gerrardii (0.09%) and C. mossambicensis 
(0.218%) . Its structure has been established from 
spectroscopic studies as epiafzelechin-(4~~8,2~~0~7)­
ent-afzelechin and is the major compound in the EtOAc soluble 
extracts from both C . gerrardii and c . mossambicensis. The 
absolute stereochemistry at the C-3 stereocenters was 
determined by application of a novel modified Mosher's method 
(Mouton, C.H.L., Steenkamp, J.A., and Ferreira, D. 
unpublished results) . 
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(40) H H H 
(40a) Me H H 
OMe 
(40b) H OC----«"I Ph (R) 
CF 3 
OMe 
(40c) H OC~ICF3 (S) 
Ph 
(40d) Me Me Me 
The positive FAB mass spectrum of (40) was identical to that 
recorded for epiafzelechin-(4~~8,2~~0~7)-epiafzelechin (38) 
(mahuannin B). The I3C_ and IH-NMR spectra of (40) were 
similar to those recorded for (38), the significant 
differences being only the chemical shifts and IH coupling 
constants of the F-ring protons and carbons . The presence of 
a 1H doublet (04.83, J=7.9SHz) in the IHNMR spectrum of (40) 
attributed to H-2(F) clearly indicates a 2,3-trans 
configuration of the lower F-ring substituents. Furthermore, 
the presence of a pair of 1H doublets (J=3.56Hz) at 04.12 and 
04 . 13 together with 13CNMR resonances at 029.5 and 0100.37 
indicate that the flavan-3-ol units are joined via a C-4(C) 
carbon-carbon linkage and a C-2(C) ether linkage. Methylation 
of (40) with ethereal diazomethane yielded the tetramethyl 
ether (40a) and not a pentamethyl ether as expected. The 
IHNMR spectrum of (40a) revealed the presence of a sharp 1H 
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singlet at 86.67. Based on the HETCOR spectrum of (40a) it 
was concluded that the proton was phenolic. The DELAYED 
HETCOR (7Hz) spectrum displayed strong coupling between the 
phenolic proton and the adjacent C-5(A) and slightly weaker 
coupling to the C- 6 (A) and C-10 (A) carbons. These results 
establish that the phenolic hydroxyl is located at position 
5(A). The unusual high field shift and uncharacteristic 
sharpness of this phenolic proton resonance, together with 
the definite non-reactivity towards diazomethane, suggests a 
through-space interaction with the lower structural unit. Of 
the three possible linkage isomers viz. (4->6,2->0->7), 
(4 ->6 , 2 ->0->5) and ( 4 ->8 , 2 ->0->7 ) 
only in the latter mode 
stereomodels suggest that it is 
of linkage that such steric 
interactions could exist. Confirmation of the mode of linkage 
was established by applying the powerful IHNOE technique to 
the tetramethyl ether (40a). Besides the stereochemically 
insignificant but structurally important NOE association of 
5(A)-OH (86 . 67) with H-4(C) (84.31, 19.1%) and H-6(A) (86.01, 
3.4%) this proton exhibited selective associations with both 
H-2' ,6' (E) and H-2(F) (87.34, d, J=6.4Hzj 84.83, d, J=7.95Hzj 
8.0% and 0.73% respectively) . These selective NOE 
associations thus establish the (4->8,2->0->7) mode of linkage 
represented by (40) . The absolute stereochemistry at C-4(C) 
for (40) was established from the sign of the Cotton effect 
near 230nm101 • Circular dichroism measurements in MeOH 
revealed a negative Cotton effect at 258nm ([8] =-5 . 8 X 10 3 ) 
and a positive Cotton effect at 232nm ([8] =1.7 x 10 3 ). This 
indicates a 4R configuration. The configuration at C-2(C) is 
thus automatically assigned. 
2.3.6.1. Configuration at the C-3(C) and C-3(F) stereocenters 
The characteristic C-ring proton signals for H-3(C) and 
H-4 (C) in the A-type proanthocyanidins invariably display 
coupling constants (J 3 , 4=3.5-4 . 0Hz) for these signals. By 
reference 
13CNMR 
to X- ray data for proanthocyanidin A-2 (27) 




consequently been accepted as being indicative of a 3,4-trans 
configuration in these type of compounds . Dreiding models of 
the A-type proanthocyanidins show very similar dihedral 
angles (ca.600) between H-3(C) and H-4(C) in both 3,4-trans 
and 3,4-cis analogues which should lead to almost identical 
coupling constants for these protons. These observations were 
confirmed by Ferreira et al. 7 1 following their unambiguous 
synthesis of robinetinidol-(4~~8,2~~O~7)-4'-OMe-catechin (58) 
which possesses the 3,4-cis configuration of the heterocyclic 
C-ring. 
OR 





Furthermore, these workers demonstrated that A-type analogues 
with the 3,4 - c i s configuration or 3,4-trans configuration 
could be differentiated on the basis of lHNOE techniques, 
which may be summarised as follows: 
Selective NOE associations were observed between H-3(C) and 
H- 8(A) in A-type proanthocyanidins with the 3,4-cis 
configuration but not in those analogues with the 3,4-trans 
configuration . In the acetate derivatives, selective NOE 
associations were only observed between H-3(C) and H-6(D) in 
those analogues with the 3,4-trans configuration. 
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Clearly, in order to complete the structure determination of 
(40), assessment of the absolute stereochemistry of not only 
the lower unit but also at the C-3(C) stereocenter is 
required. 




esters of different sets of enantiomeric flavan-3 -ols and 
4-arylflavan-3 -ols, respectively, permits assignment of the 
absolute configuration at C-3 in these compounds 104 . By 
comparing the 1HNMR data in both the R- (+) - and S- (-) -MTPA 
esters, this methodology has been extended to assess the 
absolute configuration in these compounds when only one 
isomer is available (Mouton, C.H.L., Steenkamp, J .A. and 
Ferreira, D., unpublished results) . A structural appraisal of 
the A-type proanthocyanidins revealed that this method would 
be well suited for assigning the absolute stereochemistry at 
C-3 (C) and C- 3 (F) in these compounds. The principle of the 
technique is outlined as follows: 
Mosher proposed10 2 , 103 that, in solution, the conformation of 
the R- (+) - and S- (-) -MTPA esters is such that the carbinyl 
proton, ester carbonyl and trifluoromethyl groups of the MTPA 
moiety lie in the same plane (Fig. 5.). When the MTPA group 
is in the hypothesized conformation, Mosher pointed out that 
the 1HNMR signal of L 2 of the R- (+) -MTPA ester will appear 
upfield relative to that of the S-(-)-MTPA ester due to the 
diamagnetic effect of the benzene ring. 
( OMe ) ( Ph) - - - - - - - . R - ( + ) -MTP A 





~ MTPA plane 
Fig. 5. Configurational correlation model for the R-(-)- and 
S(-)-MTPA derivatives proposed by Mosher. 
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Ferreira et al 104 have shown that the MTPA esters of 
flavan-3 -ols and 4-arylflavan-3 -ols adopt conformations 
compatible with those proposed by Mosher (Fig. S.), in which 
the cx-trifluoromethyl group, carbonyl and carbinyl hydrogen 
are in the same plane and are approximately eclipsed. Thus, 
in these compounds with a 3R configuration shielding, and 
hence an upfield shift of the B-ring proton resonances, 
occurs in the S-(-)-MTPA esters relative to the corresponding 
R- (+) -MTPA esters. Conversely, the B-ring proton resonances 
are upfield in the R-(+)-MTPA esters relative to those in the 
corresponding S-(-)-MTPA esters for those compounds with the 
38 configuration. 
The R-(+)- and S - (-) -MTPA esters (40b) and (40c) 
respectively, were prepared from the tetramethyl ether (40a) 
via standard literature procedures 102 . lHNOE association of 
H-3 (C) and H-3 (F), H-2 (F) with H-2', 6' (B) and H-2', 6' (E), 
respectively, permitted accurate labelling of these aromatic 
protons in both the R-(+)- and S-(-)-MTPA esters. lHNMR 
spectra of the R-(+)- and S-(-)-MTPA esters revealed that 
shielding, and therefore an upfield shift of both H-2' ,6' (B) 
and H-2' ,6' (E) (0-0.17 and 0-0.18, respectively) occurs in 
the S-(-)-MTPA ester relative to the R-(+)-MTPA ester. Thus, 
the R configuration may be assigned to both C-3(C) and 
C-3(F). Finally, since the relative stereochemistry between 
H-2 (F) and H-3 (F) is known, C-2 (F) may be assigned the 8 
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configuration. The heptamethyl ether derivative (40d) was 
also fully characterised and serves to confirm the proposed 
structure of (40) as epiafzelechin-(4~~8,2~~0~7)-ent­
afzelechin. 
An interesting observation may be made concerning the optical 
rotations that have been recorded for A-type 
proanthocyanidins 52 , 62, 68. Without exception, a positive 
rotation is observed in those compounds with the 
~-configuration of the interflavanoid bonds, while in those 
compounds with the a-configuration, a negative optical 
rotation is observed. 
2.3.7. 7-0Me-epiafzelechin-(4B~8,2B~0~7)-ent-afzelechin 
The novel A-type proanthocyanidin (42) was isolated from the 
stem bark of C . gummiflua (0.5%) as a white crystalline 
compound and identified as 7-0Me-epiafzelechin-(4~~8,2~~0~7)­
ent-afzelechin. It is also the major compound in the EtOAc 
soluble fraction from C. gummiflua. 
(42) Rl=R2=H 
(42a) Rl=R2=Ac 
(40a) R1=Me; R2=H 
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The 13C_ and lH-NMR spectra of (42) were very similar to 
those recorded for epiafzelechin-(4~~8,2~~O~7)-ent-afzelechin 
(40), except for the inclusion of a 3H singlet at 83.677 in 
the lHNMR spectrum and a carbon resonance at 855.63. The 
HETCOR spectrum of (42) displayed strong coupling between 
these signals. These results, together with the positive FAB 
mass spectrum which showed an [M+H] + ion at m/z 559 are 
consistent with an O-methylated A-type proanthocyanidin 
dimer. The DELAYED lH- lH COSY spectrum of (42) displayed 
strong coupling between the methoxy signal and the H-6(A) and 
H- 8 (A) signals, thus establishing the methoxy group to be 
located at position 7(A). Additional evidence for the 
location of the methoxy group at position 7(A) was obtained 
from the selective lHNOE association of this group with both 
H-6(A) and H-8(A) (17% and 14% respectively). 
Besides the methoxy resonance and the chemical shifts of 
H-6(A) and H-8(A) which are downfield (8+0.1 and 8+0.12 
respectively) relative to the corresponding signals in (40), 
the chemical shifts and coupling constants of the remaining 
proton resonances in the lHNMR spectrum of (42) are virtually 
coincident with the corresponding signals in the spectrum of 
(40) . Similarly, comparisons of the 13CNMR spectra of (42) 
and (40) reveal that besides the obvious inclusion of the 
methoxy resonance, the spectra are almost identical, with 
only slight differences being observed in the chemical shift 
positions of the A-ring carbons. These differences are in 
close agreement with the predicted chemical shift differences 
between an OH- and a OMe-substituted benzene as calculated 
from 13CNMR correlation tables 10S . These observation suggest 
that except for the methoxy group at position 7 (A), (42) is 
identical to (40) . 
Methylation of (42) with ethereal diazomethane yielded a 
tetramethyl ether identical to (40a) , thus confirming the 
structure of (42) as 7-0Me- epiafzelechin-(4~~8,2~~0~7)­
ent-afzelechin . 
64 
Acetylation of (42) with acetic anhydride in pyridine yielded 
the hexa-acetate derivative (42a) which was also fully 
characterised and which serves to confirm the proposed 
structure. 
2.3.8. 7_0Me_epiafzelechin-(4B~8,2B~0~7)-epiafzelechin 
The novel A-type dimer (43) was isolated from the stem bark 





(43a) Rl=R 2=Ac 
(38a) Rl=Me ; R2=H 
The spectral data for (43) was very similar to those recorded 
for 7-0Me-epiafzelechin- (4~~8, 2~~0~7) -ent-afzelechin (42) . 
The positive FAB mass spectrum of (43) yielded an [M+H] + ion 
at m/z 559 identical to that obtained for (42) . The 13C_ and 
IH-NMR spectra for (43) were similar to those recorded for 
(42), the significant differences being only the chemical 
shifts and IH coupling constants of the F-ring protons and 
carbons . The presence of a 1H singlet at 54.988 attributed to 
H-2(F), together with the characteristic chemical shifts and 
IH coupling constants of the remaining F- ring protons clearly 
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indicates a 2,3-cis configuration of the lower F-ring 
substituents. 
As with compound (42) selective lHNOE associations were 
observed between the methoxy resonance (84.98) and both 
H-6(A) and H-8(A) (86.128, d, J=1.85; 86.223, d, J=1.85Hz; 
11.2% and 9.2% respectively), thus establishing the location 
of the methoxy group at position 7(A). 
Comparison of the 13C_ and lH-NMR spectra of (43) to those 
recorded for epiafzelechin-(4~~8,2~~O~7) -epiafzelechin (38) 
revealed that besides the inclusion of the methoxy resonances 
the spectra were almost identical, with only minor 
differences in the chemical shifts of the A-ring protons and 
carbons. 
Methylation of (43) yielded a pentamethyl ether derivative 
(38a) identical to that obtained from the methylation of 
(38). These results thus establish the structure of (43) as 
7-0Me-epiafzelechin-(4~~8,2~~O~7) -epiafzelechin. Acetylation 
of (43) afforded the hexa-acetate derivative (43a) which was 
fully characterised and which serves to confirm the proposed 
structure. 
Two A-type proanthocyanidin glycosides 64 and a gallate 
ester 65 are presumably the only known substituted A-type 
proanthocyanidins. The isolation of compound (42) and (43) is 
thus significant and represents the first isolation of 
O-methylated A-type proanthocyanidins. 
2.3.8.1. Selective reactivity of the OH-5(A) group 
The apparently selective restricted access of diazomethane to 
OH-5(A) in A-type analogues has previously been 
reported 74 , S0. The non-reactivity of the OH-5(A) group in 
compounds (42 ) and (40) towards diazomethane may conveniently 
be explained in terms of steric effects derived from the 
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close proximity of the A- and E-rings . These steric effects 
are clearly reflected in the lHNMR spectrum of (42a) in which 
the OAc-S(A) signal resonates at unusually high field 
(82 . 044). That methylation of the OH - S (A) group proceeds 
smoothly in the epimers (43) and (38) under identical 
reaction conditions, is not as easily explained . Logic 
suggests that in these compounds, the OH-S(A) group is 
sterically less hindered than the corresponding epimers (42) 
and (40) thus permitting access to diazomethane. This then 
should be reflected by a downfield shift of the OAc-S (A) 
signal in the lHNMR spectrum of (43a) relative to the same 
signal in (42a). This is not the case and the OAc-S(A) signal 
in (43a) resonates upfield ( 8-0.1) relative to the same 
signal in (42a) . Dreiding models suggest that the distances 
between OH-S(A) and the lower unit in these compounds are not 
significantly different . Clearly then, a more plausible 
explanation must exist for the non-reactivity of OH-S(A) in 
compounds (42) and (40) . 
Based on Dreiding models hydrogen bonding between OH-S(A) and 
the F-ring heteroatom seems possible. The OH-S(A) resonance 
in the lHNMR spectrum of the tetramethyl ether derivative 
(40a) is uncharacteristically well resolved, suggesting that 
it may indeed be involved in such bonding. A closer 
inspection of the Dreiding models of these compounds reveals 
that if hydrogen bonding were to occur I the conformation 
adopted by the F-ring in compounds (42) and (40) places one 
of the lone pairs on the F-ring heteroatom in an optimal 
position for such bonding to occur. In compounds (43) and 
(38) the conformation of the F-ring is such that neither of 
the lone pairs on the heteroatom are optimally orientated for 
hydrogen bonding. 
In summary, these observations suggest that hydrogen bonding 
will only occur in those A-type dimers with a 
2(F)S-configuration combined with the (4~~8/2~~0~7) mode of 
linkage and in their corresponding enantiomers viz. those 
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compounds with a 2(F)R-configuration combined with the 
(40-+8,20-+0-+7) mode of linkage. The combination of hydrogen 
bonding, low reaction temperatures (ca.-15°C) and steric 
hindrance could well explain the apparently selective 
restricted access of diazomethane to the OH-5 (A) group in 
these compounds. 
2.3.8.2. Base catalysed rearrangement of the 7-0Me-dimers 
The 7(A)-OMe-dimers (42) and (43), differ only in their 
stereochemistry at position 2 (F). Thus, a method for the 
conversion of (42) to (43), or vice versa, byepimerization 
of the C-2 (F) stereocenter would not only sere to confirm 
the structures of these compounds, but also of their "parent" 
compounds (38) and (40). Exactly such a reaction, the base 
catalysed epimerization of epicatechin-(4~-+8,2~-+O-+7)­
epicatechin (27) has been reported 62 (Scheme 5.). In this 
report 62 , treatment of (27) with K2C0 3 in acetone under 
reflux afforded the product epicatechin-(4~-+8,2~-+O-+7)­
ent-catechin (59) in high yield (75%) after ten minutes . 
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Thus, using this method the epimerization of compound (42) at 
position C-2(F) was attempted. Surprisingly, under these 
reaction conditions (42) yielded two new compounds identified 
as 7-0Me - epiafzelechin-(4~~6,2~~0~7) -ent-afzelechin (60) and 
7-0Me-epiafzelechin-(4~~6,2~~0~7) -epiafzelechin (61) in 
moderate yields (40% and 20% respectively) after 8.5 hours . 
The reaction was monitored by TLC, and at no time was the 
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Scheme 6. Proposed route to the formation of (60) and (61) . 
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The 13C_ and lH-NMR spectra of compounds (60) and (61) were 
almost identical to those recorded for (42) and (43) 
respectively, the significant difference being the l HNMR 
shift position of H-2', 6' (E) and H-2 (F) which suggest that 
the lower unit is no longer under the steric or electronic 
influence of the upper unit . The mechanism for the formation 
of these products (Scheme 5.) presumably occurs via an E-ring 
quinone-methide (62) , followed by rotation about the 
C ( 3 )- C (4) bond and subsequent recyclization. 
Perhaps of more significance, the base catalysed conversion 
of (43) under these conditions afforded identical products to 
those obtained from the conversion of (42). These results 
thu serve to confirm the structures of both ( 42) and (43). 
2 . 3 . 9 . Epiafzelechin-(48~6)-epiafzelechin-(48~8,28~0~7)-ent 
afzelechin 
The novel A-type proanthocyanidin (41) was isolated from the 
stem bark of C . gerrardii (0.014%) as a brown amorphous 
solid and from C.mosambicensis (ca . 0.02%) as the peracetate 
derivative. 
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The positive FAB mass spectrum displayed an [M]+ ion at m/z 
816 which suggested a triflavanoid moiety . The 1HNMR spectrum 
of (41) revealed a complicated spin pattern due to rotational 
isomerism106 , 107 , 108, rendering its interpretation 
impossible . In contrast, the 1HNMR spectrum of the peracetate 
(41a) was surprisingly free of these effects . Analysis of 
this spectrum reveal ed, at lowest field in the aromatic 
region, three A2B 2 spin systems (87.66, 7.14, d , J=8.84Hzi 
87 . 40, 7.02, d , J=8.61Hzi 87.34, 7.09 d , J=8.57Hz) suggesting 
the presence of three para-substituted aromatic rings, a pair 
of meta-coupled doublets (86 . 76, 86.72, d , J=2.29Hz) and two 
residual IH singlets at 86.50 and 86.51 . 
Analysis of the aliphatic region of the spectrum was 
facilitated by a study of the 1H-1H COSY spectrum of (41a) 
which displayed three separate spin systems. Of these, a pair 
of IH doublets (J=3.77Hz) at 85.56 and 84.65 closely matched 
those of the C-ring signals in the acetylated derivatives 
(42a) and (43a) . These signals, together with the 13CNMR 
resonances at 827.379 and ketal resonance at 898.021 clearly 
indicate the presence of an A-type linkage . Furthermore, the 
presence of a strongly shielded acetoxy resonance at 82.03 in 
the 1HNMR spectrum establishes the (4~8,2~0~7) mode of 
linkage . Three proton resonances, including a IH broad 
singlet at 85 . 25, a IH doublet of doublets (85.513, J=2.44, 
1078Hz) and a IH doublet (84.796, J=2.44Hz) were in close 
agreement with the heterocyclic ring signals in peracetylated 
proanthocyanidins containing a B-type linkage 1 0 9. The 
coupling constants were also consistent with a 
2,3-cis-3,4-trans stereochemistry. The remaining spin system, 
including a 2H multiplet at 82.68 and two proton signals 
(85.3 - 5 . 4, overlapping signals) together with 13CNMR 
resonances at 822.99, 68.276 and 78.57 closely matched the 
signals of the lower heterocyclic ring in compound (42a). 
In order to establish the structures and the stereochemistry 
of the component units in (41), cleavage of the B-type 
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linkage was attempted108 . Treatment of (41) with 
phenylmethanethiol and HOAc afforded two products, 
epiafzelechin-(4~~8,2~~O~7) -ent-afzelechin (40) and a 
thioether identified as epiafzelechin-4~ -benzylthioether (63) 
by comparison of its physical and spectral data with that 
recorded in the literature 110 (Scheme 7.). 
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Scheme 7 . Thiolytic degradation of (41). 
OH 
Clearly, two possible modes of linkage exist between the 
"upper" mono' . t d merl.C unl  an the "lower" A-type unit . v~z . 
(4~~6) and (4~~8) . Selection of the mode of linkage was based 
on a comparison of the 13C_ and lH-NMR spectral properties of 
(41) with those of two related compounds (64) and (65) 
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isolated from Vaccinium vitis-idaeda 68 • 
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According to this report 68 both compounds yielded identical 
mass spectra. Upon thiolytic degradation with 
phenylmethanethiol both (64) and (65) yielded identical 
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While the 13C_ and IH-NMR spectra for (64) were first order 
those for (65) were complicated owing to the existance of 
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several conformers. This conformational isomerism was thought 
to be probably caused by steric hindrance to free rotation 
about the interflavanoid linkages. Dreiding models revealed 
that in the (4~6) linked isomer the close proximity of the B-
an H-rings could give rise to these effects, while in the 
case of the (4~8) linked isomer such steric hindrance was not 
observed. 
Based on these results, the (4~6) mode of linkage was 
assigned to (41) thus establishing its structure as 
epiafzelechin-(4~~6)-epiafzelechin-(4~~8,2~~O~7) -ent-
afzelechin. 
That essentially only one conformer is evident in the l3C_ 
and lH-NMR spectra of the acetate derivative (41a) is 
surprisingl 0 9 and can only be explained in terms of the 
increased energy barriers to rotation introduced by the bulky 
acetate groups. These increased rotational energy barriers, 
together with the steric effects between the B- and H-rings 
presumably restrict free rotation to such extent that the 
molecule is "frozen" into one conformation only. 
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3. EXPERIMENTAL 
3.1. GENERAL PROCEDURES AND INSTRUMENTATION 
Melting points were measured on a Kofler hot-stage apparatus 
and are uncorrected. Elemental analyses were determined using 
Perkin-Elmer 240B and 2400 elemental analysers. NMR spectra 
were recorded on a Gemini 200 instrument, using tetramethyl-
silane as the internal standard, in the specified solvents . 
Optical rotations were determined on a Perkin-Elmer 241 
digital polarimeter . Infra-red spectra were recorded on a 
Shimadzu FTIR-4300 spectrophotometer. 
3.1.1 . Chromatography 
HSCCC was performed on a P.C . Inc . Multilayer Coil Planet CCC 
apparatus : Coil rotation speed, 700rpm; Solvent system, 
H20-EtOAc-hexane-MeOH (30:48:24:21) , with the upper phase 
(500ml) as the mobile phase, and increasing the polarity of 
this phase in a linear fashion with water saturated EtOAc 
(500ml); Solvent flow rate, 60ml/hr; Maximum sample load, 
450mg . Reverse phase column chromatography was carried out 
with Toyopearl HW-40F (30-60~m; TosoHaas) and Sephadex LH-20 
(25-100~m; Pharmacia Fine Chemical Co., Ltd . ) with the 
eluents specified . Preparative column chromatography with 
silica gel (230-400 mesh; Merck 60) was performed using the 
technique of Still et al lll . Centrifugal TLC (Chromatotron, 
Model 7924T) was used for the separation of derivatives and 
for the final purification of minor compounds . All 
separations and reactions 
precoated Kieselgel 60 F 254 
Spots were detected with 
were monitored by TLC using 
plastic sheets (0 . 2mm; Merck) . 
benzidine or anisaldehyde-H 2S0 4 
reagents. For silica gel based separations CH2C12-Me2CO-MeOH 
with solvent ratios between (70:30:0) and (39:60:1) was used 
as the mobile phase for natural products and CH 2C1 2 -Me 2CO 
with solvent ratios between (100:0) and (95:5) for all 
derivatives, unless otherwise stated. Reverse phase HPLC was 
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conducted on a Waters system. Semi-preparative HPLC, column: 
Spheri-10 RP 18 (25 x 0.46cm); Sample load, ca. 5-10mg; The 
elution conditions were as follows: flow rate 1.5ml min -1 ; 
solvent A, 0 . 6% HOAc in aqueous MeOH (10%) buffered to pH 3.4 
with triethylamine; solvent B, MeOH; elution starting with 5% 
B with a linear gradient from 5 to 20% B in 10 min and from 
20 to 60% B in 20 min. Preparative HPLC, column: Bondapak C18 
(15-20jJm) (RCM 10 x 2.5cm); Sample load, ca. 50mg; The 
elution conditions were as follows: flow rate 7. Oml min - 1 i 
solvent, aqueous MeOH (46%) i isocratic elution. 
3.1.2. Chemical methods 
3.1.2.1. Acetylation 
The dry compound was dissolved 
pyridine/acetic anhydride (ca. 
reaction allowed to proceed 
in a 1:1 v /v mixture of 
O.lml/mg sample) 





temperature. The reaction was quenched with water and the 
product extracted with ether. 
3.1.2.2. Methylation with diazomethane 
Phenolic material (ca. 100mg) was dissolved in MeOH (ca. 
10ml) and cooled to -15 ° C. Diazomethane was generated by 
hydrolysis 
20g) with 
of N-methyl-N-nitrosotoluene-p-sulphonamide (ca. 
40% KOH (aq) (ca. 50ml) and collected as an 
ethereal solution (ca. 200ml) at -lS0C. The ether layer was 
decanted, dried over KOH pellets (3x) and added to the MeOH 
solution. The reaction was allowed to proceed for 24 hours at 
-lSoC, after which excess diazomethane was allowed to 
evaporate at room temperature. 
3.2. EXTRACTION AND ISOLATION 
Air dried and powdered stem bark of C. gerrardii (2.48kg) was 
exhaustively extracted (Soxhlet) with EtOH (9S%) and the 
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combined extracts concentrated to dryness under reduced 
pressure. The residue was suspended in water and successively 
extracted with hexane, CHCl 3 and EtOAc. Evaporation of the 
EtOAc fraction afforded a residue (lOg) which was 
fractionated on silica gel by column chromatography using 
CHCI3-Me2CO (2:3) as eluent. This solvent removed less polar, 
non-phenolic contaminants. The residue (8.0g) was applied to 
a Sephadex LH-20 column and eluted with EtOH (95%), 
collecting 6ml fractions: tubes 38-58 afforded a mixture of 
compounds (36), (37) and (39) ; tubes 60-100 contained 
compounds (38), (40) and (41). Further silica gel based 
separations of these fractions afforded (36) and (37) as a 
diastereomeric mixture (80mg), (39) (170mg), (38) and (40) as 
a diastereomeric mixture (3.0g) and (41) (340mg). 
Air dried and powdered stem bark of C. gummiflua (2.93kg) was 
exhaustivly extracted (Soxhlet) with EtOH (95%) and the 
combined extracts concentrated to dryness under reduced 
pressure. The residue was suspended in water and successively 
extracted with CHCl3 and EtOAc. Evaporation of the EtOAc 
fraction afforded a residue (51.0g) of which a portion (lOg) 
was fractionated on silica gel using CH 2Cl 2 -acetone (70:30 -
25:65, in step-wise increments) to yield compounds (42) and 
(43) as a diastereomeric mixture (2.8g) and a phenolic rich 
fraction (4.3g). The phenolic fraction was subjected to 
column chromatography on Sephadex LH-20 and eluted with 
increasing amounts of MeOH in water in step-wise increments 
(50:50-80:20) to afford (39) (133mg), (36) (170mg), (44) 
(151m~) and an oligomeric fraction (3.3g). Further silica gel 
based separations of this fraction afforded (38) and (40) 
(0.86g) and further quantities of (42) and (43) (0.8g) as 
diastereomeric mixtures . 
Air dried and powdered stem bark of C. mossambicensis (1.6kg) 
was exhaustively extracted (Soxhlet) with EtOH (95%) and the 
combined extracts concentrated to dryness under reduced 
pressure. The residue was suspended in water, defatted with 
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CHC13 and extracted with EtOAc. Evaporation of the EtOAc 
fraction afforded a residue (21.0g) of which a portion (lOg) 
was fractionated on silica gel using CH 2C1 2-acetone (75:25 -
30:70, in step-wise increments) to give three fractions: fro 
1 (3.7g), fro 2 (777mg) and fro 3 (l.lg). Each fraction was 
subjected to chromatography over Sephadex LH-20 and eluted 
with increasing amounts of MeOH in water in step-wise 
increments (60:40-100:0). Following further silica gel based 
separations: fro 1 afforded compounds (45) (50mg), (36) and 
(37) as a diastereomeric mixture (74mg) and (38) and (40) as 
a diastereomeric mixture (2.0g); Fr. 2 yielded two compounds 
as an inseparable mixture (450mg). Acetylation of this 
mixture with acetic anhydride in pyridine and subsequent 
separation on silica gel afforded (41a) (180mg) and a 
compound of unresolved structure (ca.80mg); Fr. 3 afforded 
compound (39) (224mg) . 
3 . 2.1 . Separation of diastereomers 
Compounds (36) and (37 ) were separated by semi-preparative 
HPLC (Rt13.4 and 15.4min respectively) . Compounds (42 ) and 
(43 ) were separated using HSCCC (Rt 8.0 and 7.3hr 
respectively) . Separation of compounds (38 ) and ( 40) was 
achieved using reparative HPLC (R t15.7 and 11.4min 
respectively) and by HSCCC (Rt11.5 and 12.1hr respectively) . 
3 . 3 . SPECTRAL DATA 
Afzelechin (36). A pale yellow crystalline solid, mp 176°C, 
Rf 0.46 [CH 2C1 2 -acetone (55:45)]; FAB-MS m/z 275 [M+H]+; 
[ ]24 ° 24 
o D +19 . 32 (MeOH; c 0 . 176), [0]546 +22.16° (MeOH; c 0.176); 
IHNMR (Me2CO-d6): 02.53 [lH, dd, J= 8.5, 16.0Hz, H-4(C)eq], 
2.95 [lH, dd, J=5.3, 16.0Hz, H-4(C)ax], 4.04 [lH, m, H-3(C)], 
4 . 59 [lH, d, J=7 . 7Hz, H-2(C)], 5.87 [lH, d, J=2.3Hz, 
H-6(A)], 6 . 02 [lH, d, J=2 . 3Hz, H-8(A)], 6.81 [2H, d, J=8.7Hz, 
H-3',5'(B)], 7 . 25 [2H, d, J=8 . 7Hz, H-2',6'(B)]; 8.08, 8.27 
and 8,40 [each 1H, 5 , 3 X OH]; 1 3CNMR (Me2CO-d6) : 029.08 
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[C-4(C)], 68.24 [C-3(C)], 82.57 [C-2(C)], 95.34 [C-8(A)], 
96 . 03 [ C - 6 (A)], 100. 60 [ C - 10 (A)], 115. 67 [ C - 3' , 5' (B)], 12 9 . 55 
[C-2' , 6' (B)], 131.24 [C-1 ' (B)], 156.85, 157.09, 157.62 and 
157.92 [C-4' (B), C-5 (A), C-7 (A), and C-9 (A)] . 
Epiafzelechin (37). A pale yellow crystalline solid, mp 
241°C, Rf 0.46 [CH2C12-acetone (55:45)] j FAB-MS m/z 275 
23 23 ° ( [M+H]+j [cx]D -51.52° (MeOHj c 0.066), [cx]546-62.12 MeOHj c 
0.066)j 1HNMR (Me2CO-d6): 82.73 [lH, dd, J= 3.1, 16.7Hz, 
H-4(C)eq], 2.89 [lH, dd, J=4.3, 16.7Hz, H-4(C)a x], 3.66 [lH, 
d, J=5.86, OH-3(C)], 4.19 [lH, m, H-3(C)], 4.92 [lH, br5, 
H-2(C)], 5 . 91 [lH, d, J=2.3Hz, H-6(A)], 6.01 [lH, d, J=2.3Hz, 
H-8(A)], 6.80 [2H, d, J=8.7Hz, H-3',5'(B)], 7.35 [2H, d, 
J=8 . 7Hz, H-2',6'(B)], 7 . 99, 8.16 and 8.29 [each 1H, 5 , 3 X 
OH]; 13CNMR (Me 2CO-d6): 829.10 [C-4(C)], 66.80 [C-3(C)], 
79 . 43 [C-2(C)], 95 . 66 [C-8(A)], 96.13 [C-6(A)], 99.69 
[C-10(A)], 115.41 [C-3',5'(B)], 129.10 [C-2',6'(B)], 131.46 
[ C - I' (B) ], 15 7 . 15 , 15 7 . 53 , and 2 X 15 7 . 59 [ C - 4' (B), C - 5 (A) , 
C-7(A), and C-9(A)] . 
Epiafzelechin-(4~~8,2~~0~7) -epiafzelechin (38). Isolated as a 
pale yellow amorphous powder, mp 220-223°C, Rf 0.34 
25 [CH 2Cl r acetone (55:45)]; FAB-MS m/ z 545 [M+H]+j [cx]D +54 . 21° 
(MeOHj c 0.107), [CX]::5 +199.07° (MeOHj c 0.107) j CD [8] 2120.0, 
[8] 2 2271.9 X 10 3 , [8]2560.0, [8]2 71 -16.6 X 10 3 j 1HNMR 
(CD 30D): 82.79 [lH, dd , J=1.95, 17.15Hz, H-4(F) eq] , 3.00 [lH, 
dd , J=4.95, 17.15Hz, H-4(F)a x], 4.10 [lH, d , J=3.45Hz, 
H-3(C)], 4.258 [lH, m, H-3(F)], 4.46 [lH, d, J=3.45Hz, 
H-4 (C)], 5.00 [lH, brs , H-2 (F)] , 6.05 [lH, d , J=2. 57Hz, 
H-6(A)], 6.11 [lH, d, J=2.57Hz, H-8(A)] , 6.13 [lH, s , 
H-6(D)], 6.86 [2H, d , J=8.81Hz, H-3',5'(B)], 6.87 [2H, d , 
J=8.81Hz, H-3',5' (E)], 7.54 [4H, d , J=8.81Hz, H-2',6' (E), 
H-2' ,6' (B) ] j 13CNMR (CD 30D): 829.25 [C-4 (C) ], 29.94 [C-4 (F) ] , 
67 . 02 [ C - 3 (F) ], 68 . 02 [ C - 3 (C) ], 81 . 64 [ C - 2 (F) ], 96 . 49 and 
9 6 . 54 [ C - 6 (D), C - 8 (A) ], 9 8 . 22 [ C - 6 (A) ], 100 . 2 6 [ C - 2 (C) ], 
102.37, 104.14 and 107.20 [C-10(A), C-8(D) and C-10(D)], 
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115.49 [C-3',S'(B)], 115 . 9 [C-3',S'(E)], 129.45 [C-2',6'(E)], 
129.94 [C-2',6'(B)], 130.60 [C-l'(E)], 131.82 [C-l'(B)], 
152.19, 




154 . 24 , 156 . 57, 157. 05 , 158 . 07, 158 . 27 and 
C-S (D), C-7 (A), C-7 (D), C-9 (A), C-9 (D) , 
and C - 4' (E) ] . 
Epiafzelechin-(4~~8,2~~0~7) - epiafzelechin-pentamethyl ether 
(38a) . Methylation of (38) with ethereal diazomethane, 
afforded (38a) as an amorphous powder, mp 135°C, Rf 0.27 
23 
[CH 2C1 2-acetone (97 : 3)]; [a]D +6l.36° (CHC1 3 ; c 
0 . 176) [a]::6+73 . 86° (CHC1 3 ; c 0.176); IR vrna xcm -
1
: 1612, 
1515, 1250; IHNMR (CDC13): 6l.88 [lH, brs , OH-3(F)], l.94 
[lH., d , J=S.94Hz, OH-3(C)], 2.84 [2H, m, H-4(C)], 3.49 [3H, 
s , OMe-S(A)], 3.72 and 3.74 [each 3H, s, OMe-7(A) and 
OMe-S (D) ] , 3 . 81 and 3 . 82 [each 3H, s , OMe-4' (B) and 
OMe-4 ' (E)], 4 . 17 [lH, dd , J=3.44, S.94Hz, H-3(C)], 4.41 [lH, 
m, H-3(F)], 4 . 93 [lH, d, J=3 . 44Hz, H-4(C)], 4.96 [lH, brs , 
H-2(F)], 6.06 [lH, d , J=2 . 33Hz, H-6(A)], 6.20 [lH, s , 
H-6(D)], 6.28 [lH, d , J=2.33Hz, H-8(A)], 6.957 [4H, d , 
J=8.89Hz, H-3',S' (B) and H-3',S' (E)], 7.60 [2H , d , J=8.89Hz, 
H-2',6'(E)], 7 . 66 [2H, 
(CDC1 3): 627 . 58 [C-4 (C) ] , 
55 . 47 [5 X OMe], 65 . 52 
[C-2 (F)], 92.06 [C-6 (D)] , 
d , J=8. 89Hz, H-2', 6' (B) ]; 13CNMR 
28.86 [C - 4(F)], 
[C-3(F)], 67.42 
83.10 [C- 8 (A) ] , 
55 . 34 , 55 . 30 and 
[C-3(C)], 78.24 
93.30 [C-6(A)], 
98 . 88 [C-2(C)], 103.64 [C-10(A)], 106.69 [C-8(D)], 113.62 and 
113 . 69 [C - 3' , 5' (E) and C - 3' , 5' (B) ], 127 . 98 [ C - 2' , 6' (E) ] , 
128 . 10 [C-2',6'(B)], 130.09 [C-l'(E)], 130.60 [C - l'(B)], 
lSl.23 [C-9(D)], 151.61 [C-7(D)], 152 . 94 [C-9(A)], 157.63 
[C-S (D) ], 158 . 98 [C - S (A) ], 159 . 24 [C-4' (E) ], 159 . 87 [C-7 (A) ] , 
160 . 13 [C-4' (B) ] . 
Epiafzelechin-(4~~8,2~~0~7) -epiafzelechin-pentamethyl ether 
diacetate (38b) . Acetylation of (38a) afforded (38b) as an 
amorphous powder, mp 145°C, Rf 0.33 
\ 
(CHC1 3 ; c 0 . 462), [a]~~6 +6 . 49° (CHC1 3 ; c 0 . 462); 
IRv rnax Cm- 1 :1742, 1614, 1516, 1123; IHNMR (CDC1 3): 6l.79 and 
80 
1.88 [each 3H, s, OAc-3 (C), OAc-3 (F)], 2.77 [lH, dd, J=2. 50, 
17.95Hz, H-4(F)eq], 3.02 [lH, dd, J=5.13, 17.95Hz, H-4(F)ax], 
3.56 [3H, s, OAc-5(A)], 3.82, 3.73, 3.78 and 3 . 82 [each 3H, 
s, OAc-4' (E), OAc-5(D), OAc-7(A) and OAc-4' (B)], 4.91 [lH, d, 
J=3. 33Hz, H-4 (C)], 5.11 [lH, brs, H-2 (F)], 5.45 [lH, d, 
J=3.33Hz, H-3(C)], 5 . 60 [lH, m, H-3(F)], 6.10 [lH, d, 




6 . 21 [ 1H, s , H - 6 (D) ] , 
6 . 92 [4H, d, J=8.78Hz, 
6.31 [lH, d, 
H - 3' , 5' (B) and 
H-3',5'(E)], 7.49 [2H, d, J=8.78Hz, H-2',6'(E)], 7.63 [2H, d , 
J=8.78Hz, H-2',6'(B)]j 13CNMR (CDC1 3): 820.77 and 20.98 
[ OCO~H 3 - 3 (C) and - 3 (F) ], 25 . 76 [ C - 4 (C) ], 25 . 87 [ C - 4 (F) ] , 
55 . 23, 55.34 and 55.45 [5 X OMe], 67.39 [C-3(F)], 67 . 86 
[C-3(C)], 76.66 [C-2(F)], 91.78 [C-6(D)], 93.02 [C-6(A)], 
93.42 [C-8(A)], 97.46 [C-2(C)], 101.48 [C-10(D)], 104 . 33 
[ C - 10 (A) ], 106 . 25 [ C - 8 (D) ], 113 . 3 3 and 113 . 66 [ C - 3' , 5' (B) , 
and C - 3' , 5' (E) ], 127 . 64 [ C - 2' , 6' (E) ], 128 . 03 [ C - 2' , 6' (B) ] , 
129.83 [C-1'(E)], 130.35 [C-1'(B)], 151.27 [C-9(D)], 151.78 
[C-7 (D)], 153.15 [C-9 (A)], 157.34 [C-5 (D)], 158.69 [C-5 (A)] , 
159 . 15 [C-4' (E) ], 159.70 [C-7 (A) ], 160.10 [C-4' (B) ], 169.39 
and 170.36 [0~OCH3-3(C) and -3(F)]. 
Afzelechin-3-0-a-L-rhamnopyranoside (39) . This is a 
semi-crystalline hygroscopic powder, mp 110-115°C, Rf 0.23 
[CH 2C1 2- acetone (2:3)]j FAB-MS m/z 421 [M+H]+j [a]~ 8 -14 . 95 ° 




5 -37.38° (Me2COj C 0 . 107)· UV AMeOHnm ' , ma x • 
213 , 224 , 2 7 9 j I R V m a x cm - 1: 33 84 , 1614 , 131 7 , 1141 j 1 HNMR 
(Me2CO-d6): 81.26 [3H, d, J=6.20Hz, H-6"], 2.67 [lH, dd, 
J=16.27, 8.18Hz, H-4(C) eq], 2 . 92 [lH, dd, J=16.27, 5.71Hz, 
H-4(C) ax], 3.42 [lH, dd, J=9.44, 9.44Hz, H-4"], 3.56 [lH, dd, 
J=3.35, 1.57Hz, H-2"], 3 . 65 [lH, dd, J=9.43, 3.35Hz, H- 3"], 
3 . 73 [lH, dq, J =9.44, 6.20Hz, H-5"], 4.02 [lH, ddd, J=7 . 85, 
5.71, 8,18Hz, H-3(C)], 4.33 [lH, d, J=1.57Hz, H-1"], 4.74 
[lH, d, J=7.85Hz, H-2(C)], 5 . 94 [lH, d, J=2.29Hz, H-6(A)], 
6.09 [lH, d, J=2.29Hz, H-8(A)], 6.88 [2H, d, J=8 . 57Hz, 
H-3',5'(B)], 7.28 [2H, d, J=8.57Hz, H-2',6'(B)], 8.2 [lH, s, 




0D): 81.28 [3H, d, J=6.22Hz, H-6"], 2.68 [lH, dd, 
J=16.08, 8.57Hz, H-4(C) eq], 2.95 [lH, dd, J=16.08, 5 . 72Hz, 
H-4(C) ax], 3.33 [lH, dd, J=9.43, 9.43Hz, H-4"], 3.50 [lH, dd, 
J=3.30, 1 . 66Hz, H-2"], 3.61 [lH, dd, J=9.43, 3.30Hz, H-3"], 
3.72 [lH, dq, J =9.43, 6.22Hz, H-5"], 3.97 [lH, ddd, J=8.00, 
5.57, 8,57Hz, H-3(C)], 4 . 29 [lH, d, J=1.66Hz, H-1"], 4.69 
[lH, d, J=8.00Hz, H-2(C)], 5.89 [lH, d, J=2.30Hz, H-6(A)], 
5 . 98 [lH, d, J=2.30Hz, H-8(A)], 6.82 [2H, d, J=8.53Hz, 
H-3' ,5' (B)], 7.25 [2H,d,J=8 . 53Hz,H-2' ,6' (B)]; 13CNMR 
(Me2CO-d6): 817.94 [Me-6"], 27.89 [C-4(C)], 69.67 [C-5"], 
71.51 [C-2"], 72.29 [C-3"], 73.66 [C-4"], 74.82 [C-3(C)], 
80 . 45 [ C - 2 (C) ], 95 . 52 [ C - 6 (A) ], 96 . 41 [ C - 8 (A) ], 100 . 3 5 
[C-10(A)], 101.49 [C-1"], 115.99 [C-3',5'(B)], 129.38 
[C-2',6'(B)], 131.09 [C-1'(B)], 156.91,157.38,158.04 and 
158.32 [C-5 (A), C-7 (A), C-9 (A) and C-4' (B) ] . 
Enzymic hydrolysis of compound (39). The glycoside (45mg) was 
dissolved in an acetate buffer (0.02M, 10ml, pH 3.8) and 
incubated (40°) with hesperidinase (20mg) for 12hr. 
Extraction with EtOAc afforded the crude aglycone, which, 
after separation over silica gel was identified as afzelechin 
(36) by comparison with an authentic sample. The sugar 
residue was confirmed to be rhamnose by Co-TLC with an 
authentic sample. 
Afzelechin-3-0-0-L-rhamnopyranoside-hexa-acetate (39a) . 
Amorphous powder, mp 69°C; (Found: C, 58.52; H, 5.62. 
requires: C, 58.92; H c 
0.180), [0];:5 +90.0· (Me2CO; c 0.180); UV A~!~H nm: 210; IR 
vrnaxcm- 1 : 3430, 1753, 1620, 1130; IHNMR (CDCL 3 ): 81.17 [3H, 
d, J=6.28Hz, H-6"], 1.96, 2,04 and 2.05 [each 3H, s, OAc-2", 
-3" and -4"] 2.27, 2.28 and 2.33 [each 3H, s, OAc-5(A), -7(A) 
and -4'(B)], 2.78 [lH, dd, J=16.36, 9 . 09Hz, H-4(C)eq], 2.90 
[lH, dd, J=16,36, 6.13Hz, H-4(C) ax], 3.85 [lH, dq, J=9.82, 
6.28Hz, H-5"], 3.97 [lH, m, H-3(C)], 3.99 [lH, d, J=1.61Hz, 
H-1"], 4.87 [lH, d, J =8.46Hz, H-2 (C)], 4.95 [lH, dd, J=1.61, 
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3.43Hz, H-2"], 4.97 [lH, dd, J=9.86, 10.03Hz, H-4"], 5.21 
[lH, dd, J=10.03, 3.43Hz, H-3"], 6.58 [lH, d, J:2.21Hz, 
H-6(A)), 6.63 [lH, d, J:2.21Hz, H-8(A)), 7.09 [2H, d, 
J:8.52Hz, H-3',5'(B)), 7.43 [2H, d, J:8.52Hz, H-2',6'(B)); 
13CNMR (CDCL 3): 817.28 [Me-6"], 20.67, 20 . 79 and 21.03 [6 X 
OCO~H3]' 27.54 [C-4(C)], 67.09 [C-5"], 68.81 and 68.85 [C-3", 
C-2"], 70.82 [C-4"], 74.37 [C-3(C)], 79.48 [C-2(C)], 97.98 
[C-1"), 107.82 [C-8(A)), 108.73 [C-6(A)), 111.03 [C-10(A)], 
122.02 [C-3',5'(B)), 127.84 [C-2',6'(B)), 134.97 [C-1'(B)), 
149 . 29 , 149 . 80, and 150 . 86 [ C - 5 (A), C - 7 (A) and C - 4' (B) ] , 
155 . 03 [ C - 9 ( A) ], 16 8 . 34 , 16 8 . 94 , 169 . 02 , 169. 5 8 , 169 . 85 and 
169 . 99 [6 X O~OCH 3] . 
Epiafzelechin- (413--+8,213--+0--+7) -ent-afzelechin (40) . This is an 
amorphous , hygroscopic powder, mp 238-245°C, Rf 0.31 
[CH 2C1 2-acetone (50:50)]; FAB-MS m/z 545 [M+H]+; [a]~5+64.29° 
(MeOH; c 0.126), [a]~:5 +199.21° (MeOH; c 0.126); uv A~:~Hnm 
23 7 . 0 , 2 3 7 . 2 ; I R v m a x cm - 1: 3492 , 1614 , 1516 , 1140 , 832 ; CD 
[8] 200+0.73 X 10 3 , [8] 232+1.7 X 10 3 , [8] 24 10.0, [8] 258-5.8 X 
10 3 , [8] 2850.0; 1HNMR (CD 30D): 82.63 [lH, dd, J:8.39, 
16.41Hz, H-4(F) eq], 2 . 99 [lH, dd, J:5.60, 16.41Hz, H-4(F) ax], 
4.12 [lH, d , J:3 . 56Hz, H-3(C)], 4.21 [lH, ddd , J:8.39, 5 . 60, 
7 . 95Hz, H-3(F)], 4.31 [lH r d, J:3.56Hz, H-4(C)], 4.83 [lH, d , 
J:7.95Hz, H-2(F)], 6.01 [lH, d , J:2.22Hz, H-6(A)], 6.13 [lH, 
d, J=2.22Hz, H-8(A)), 6.15 [lH, s , H-6(D)), 6.85 [2H, d, 
J:8.89Hz, H-3',5'(B)), 6.88 [2H, d, J:8.57Hz, H-3',5'(E)], 
7.34 [2H, d, J=8.57Hz, H-2',6'(E)), 7.55 [2H, d, J=8.89Hz, 
H - 2' , 6' (B) ]; 1 3 CNMR ( CD 3 OD): 829 . 15 [ C - 4 (C) and C - 4 (F) ] , 
67.66 [C-3(C)], 68.04 [C-3(F)], 84.14 [C-2(F)], 96.48 and 
9 6 . 53 [ C - 6 (D), C - 8 (A) ), 98 . 06 [ C - 6 (A) ], 100 . 3 7 [ C - 2 (C) ], 
103 . 1 [C-10(D)), 103.93 [C-10(A)), 106.74 [C-8(D)), 115.48 
[C-3',5'(B)), 116.26 [C-3',5'(E)), 129.46 [C-2',6'(B)], 
129.80 [C-1' (E) ), 130.10 [C-2', 6' (E) ), 131.57 [C-1' (B)], 
151.40 [C-9(D)], 152.09 [C-7(D)], 154.20 [C-9(A)], 156.03 
[C-5(D)], 156.69 [C-5(A)], 158.01 [C-7(A)], 158.66 [C-4'(B)], 
158.76 [C-4' (E)] . 
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Epiafzelechin-(4~~8,2~~0~7) _ent-afzelechin-tetramethyl ether. 
(40a). Methylation of (40) with ethereal diazomethane 
afforded (40a) as an amorphous powder, mp 152-154°C, Rf 0.13 
[CH2C1 2-acetone (95:5)]; [a] ~ 5 +40.00 ° (CHC1 3 ; c 
0.095), [a]~:5 +104.21° (CHC13; c 0.095); IRvmaxcm- 1 : 3445, 
1603, 1516, 1252, 1036, 831; lHNMR (CDC13): 02.00 and 2.03 
[each 1H, 5 , OH-3 (C) and OH-3 (F) ], 2.57 [lH, dd, J=16. 58, 
9.02Hz, H-4(F) eq], 3.06 [lH, dd, J=16.58, 5.94Hz, H-4(F) a x], 
3.81,3.74,3.81 and 3.70 [each 3H, 5, OMe-4'(E), -5(D), 
-4'(B) and -7(A)], 4.12 [lH, d, J=3.65Hz, H-3(C)], 4.13 [lH, 
m, H-3(F)], 4.27 [lH, d , J=3.65Hz, H-4(C)], 4.73 [lH, d , 
J=8. 63Hz, H-2 (F)], 6.13 
5 , H - 6 (D) ], 6 . 27 [lH, 
OH-5(A)], 6.96 [2H, d, 
[lH, d , J=2.47Hz, H-6(A)], 6.25 [lH, 
d, J=2.47Hz, H-8(A)], 6.67 [lH, 5, 
J=8.92HZ, H-3' ,5' (B)], 6.98 [2H, d , 
J=8.70Hz, 
7.64 [2H, 
[C-4 (C)] , 
-4' (E), 
H-3' ,5' (E)], 7.38 [2H, d , J=8. 70Hz, H-2' ,6' (E)], 
d , J=8.92Hz, H-2',6'(B)]; 13CNMR (CDC1 3): 027.40 
28 . 01 [ C - 4 (F) ], 55 . 30- 5 5 . 64 [OMe - 7 (A) , - 5 (D) , 
-4'(B)], 66.52 [C-3(C)], 67.34 [C-3(F)], 83.37 
[ C - 2 (F) ], 93 . 00 
99.07 [C-2(C)], 
[C-8(D)], 113.65 
[C-6(D)], 94.72 [C-8(A)], 96.90 [C-6(A)], 
102.51 [C-10(A)], 103.28 [C-I0(D)], 105.61 
[C-3' ,5' (B) ], 114.56 [C-3', 5' (E) ], 127.74 
[C-1'(B)], 128.22 [C-2',6'(B)], 129 . 3 [C-2',6'(E)], 130.12 
[ C - l' (E) ], 149 . 67 [ C - 9 (D) ], 150 . 96 and 152 . 3 6 [ C - 9 (A) and 
C-7(D)], 155.25 [C-5(A)], 157.30 [C-5(D)], 159.94 [C-7(A)], 
160.21 [C-4' (B)], 160.45 [C-4' (E)] . 
Epiafzelechin-(4~~8,2~~0~7) -ent-afzelechin-heptamethyl ether . 
(40d). NaH (3 eq.) was added to a stirred solution of (40) 
(70mg) in anhydrous THF (30ml) at 0°. The mixture was stirred 
at room temperature for 30 min, treated with MeI (3 eq.) and 
stirred for a further 6 hr. The reaction was quenched with 
water and extracted with ether. Purification by flash 
chromatography (CH 2C1 2) afforded the heptamethyl ether (42mg) 
as a pale yellow amorphous powder, mp 134°C, [a]~5-78.0° 
84 
(CHC1 3; c 0.100), [0] ~:5 -332.0 0 (CHC1 3; c 0.100); IRvrna xcm -
1
: 
1615, 1518, 1250, 1115, 1040; MS m/z (reI. int.): 642 . 2397 
[M] + (30) (calc. for C37H3S010, 642.2465), 611 (52), 447 
(41), 164 (64), 149 (100), 121 (57), 91 (69); lHNMR (CDC1 3): 
82.44 [lH, dd, J=16 . 95, 4 . 53Hz, H-4(F)eq], 2.73 [lH, dd , 
J=16.95, 3.85Hz, H-4(F)a x], 2.97 [3H, s , OMe-3(C)], 3.24 [3H, 
s, OMe-5(A)], 3.35 [3H, s , OMe-3(F)], 3.65 [3H, s , OMe-5(D)], 
3.69 [lH, m, H-3(F)], 3.70, 3.71 and 3.77 [each 3H, s , 
OMe-4' (E), -4' (B) and -7 (A)], 3.79 [lH, d , J=3.59Hz, H-3 (C)], 
4.99 [lH, d , J=3.59Hz, H-4(C)], 5.21 [lH, d , J=7.23Hz, 
H-2(F)], 5.94 [lH, d , J=2.32Hz, H-6(A)], 6.13 [lH, s , 
H-6(D)], 
J=8.72Hz, 
6.24 [lH, d , J=2.32Hz, 
H-3',5'(E)], 6.90 [2H, 
H-8(A)], 6.74 [2H, d , 
d , J = 8 . 91Hz, H - 3' , 5' (B) ] , 
7.10 [2H, d, J=8.72Hz, H-2',6'(E)], 7.61 [2H, d , J=8.91Hz, 
H - 2' , 6' (B) ]; 1 3 CNMR (CDC1 3): 821.46 [C - 4 (F) ], 24. 47 [C - 4 (C) ] , 
54 . 8 8 - 57 . 3 9 [ 7 X OMe], 75. 67 [ C - 3 (C) ], 7 6 . 01 [ C - 3 (F) ], 7 8 . 23 
[C-2(F)], 91.61 [C-6(D)], 92.31 [C-6(A)], 92.80 [C - 8(A)], 
98 . 42 [C-2(C)], 101.29 [C-10(D)], 104.30 [C-10(A)], 105.72 
[C-8(D)], 113.15 [C-3',5'(B)], 113 . 54 [C-3',5'(E)], 127.38 
[C-2',6'(E)], 128.30 [C-2',6'(B)], 131.37 [C-1'(E)], 131.40 
[C - 1' (B) ], 151. 04 [ C - 9 (D) ], 151. 40 [C - 7 (D) ], 153. 72 [C - 9 (A) ] , 
157.09 [C-5 (D) ] , 158.19 [C-5 (A) ] , 158 . 96 [C-4' (E) ] , 
159.51 and 159.80 [C-4' (B) and C-7 (A) ] . 
Epiafzelechin-(4~~6)-epiafzelechin-(4~~8 , 2~~O~7)-ent-
afzelechin (41). Brown amorphous solid; Rf 0.14 
[CH2C12-acetone-MeOH (50:49:1)]; FAB-MS m/z 816 [M] +. 
Acid-catalysed thiolytic degradation of (41) . A mixture of 
(41) (200mg), benzylmercaptan (l.5ml) and HOAc in MeOH (10ml) 
was refluxed under N 2 for 8hr. The reaction mixture was 
concentrated under reduced pressure and the residue 
chromatographed over silica gel to afford two products, 
epiafzelechin-(4~~8,2~~0~7) -ent-afzelechin (40) (50mg) and 
epiafzelechin-4~-benzylthioether (63) (18mg). 
Epiafzelechin-4~-benzylthioether (63). Amorphous solid, mp 
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106-108·C, (Found: C, 64.01; H, 5.09. C22H200S · lH 20 requires 
C, 63.75; H, 5 . 35%); [a]~3-17.02· (MeOH; c 0.094); lHNMR 
(CD 30D ): 5 3.87 [lH, dd, J=2.37, 0 . 97Hz, H-3(C)], 3.99 [2H, 
S, CH 2S-()], 4.11 [lH, d, J=2.37Hz, H-4(C)], 5.32 [lH, brs, 
H-2(C)], 5.95 [lH, d, J=2.33Hz, H-6(A)], 6 . 01 [lH, d, 
J=2.33Hz, H-8(A)], 6.80 [2H, d, J=8.46Hz, H-3',5(B)], 7.23 
[2H, d, J=8.46Hi, H-2',6'(B)], 7.25-7 . 47 [5H, m 
(toluene-thiolyl ring protons)]; 1 3CNMR (CD 30D): 538.35 
[ CH 2 S], 44. 42 [ C - 4 (C) ], 71. 87 [ C - 3 (C) ], 75. 8 8 [ C - 2 (C) ], 9 6 . 09 
[C-8(A)], 97.01 [C-6(A)], 100.46 [C-10(A)], 116.12 
[C-3',5'(B)], 128.25 [C-4(toluene-thiolyl ring)], 129.34, 
12 9 . 8 7 and 130 . 3 8 [ C - 2' , 6' (B) , C - 3 , 5 and 
C-2, 6 (toluene-thiolyl ring) ] , 131 . 67 [C-1' (B) ] , 140.97 
[C-1(toluene-thiolyl ring)], 157.57, 158.11, 159.17 and 
159 . 33 [ C - 5 (A), C - 7 (A), C - 9 (A) and C - 4' (B) ] . 
Epiafzelechin-(4~~6)-epiafzelechin-(4~~8 , 2~ ~O~7) -ent­
afzelechin peracetate (41a). Acetylation of (41) afforded the 
peracetate (41a) as an amorphous solid.1HNMR (CDC1 3): 
51.74-2.35 [each 3H, s, 11 X OAc], 2 . 86 [2H, m, H-4(I)], 4 . 65 
[lH, d, J=3.77Hz, H-4(F)], 4.80 l[H, d, J=2.44Hz, H-4(C)], 
5.25 [lH, brs, H-2(C)], 5 . 3-5 . 4 [2H, overlapping signals, 
H-2(I) and H-3(I)], 5.51 [lH, dd, J=2.44, 1.78Hz, H- 3(C)], 
5 . 56 [lH, d, J=3.77Hz, H-3(F)], 6.51 and 6.52 [each 1H, s , 
H-8(D) and H-6(G)], 6 . 72 [lH, d, J=2 . 29Hz, H-6(A)], 6 . 76 [lH, 
d, J=2.29Hz, H-8(A)], 7.02 [2H, d, J=8.61Hz, H-3',5'(B)], 
7.09 [2H, d, J=8.57Hz, H-3',5'(H)], 7.14 [2H, d, J=8.84Hz, 
H- 3',5'(E)], 7.34 [2H, d, J=8.87Hz, H-2',6'(H)], 7.40 [2H, d, 
J=8.61Hz, H-2',6'(B)], 7.66 [2H, d, J=8.84Hz, H-2',6'(E)]; 
13CNMR (CDC1 3): 5 19 . 95-21.14 [11 X OCO.cH3], 22.99 [C-4(I)], 
27.38 [C-4(F)], 34.71 [C-4(C)], 66.55 [C-3(F)], 68.28 
[C-3(I)], 70.29 [C-3(C)], 74.87 [C-2(C)], 78.86 [C-2(I)], 
98.02 [C-2(F)], 103 . 85 [C-6(G)], 106.17 [C-10(G)], 107.72 
[C-8(D)), 109.20 [C-8(G)], 108 . 92 [C-8(A)], 111.14 [C-10(A)], 
111.35 [C-6(A)], 113.43 [C-10(D)], 116.41 [C-6(D)], 121.31, 
121. 39 and 121. 82 [C-3' ,5' (B) , C-3' ,5' (E) and 
C - 3' , 5' (H) ] , 127 . 71, 12 7 . 81 and 12 7 . 90 [ C - 2' , 6' (B), C - 2' , 6' (E) 
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and C - 2' , 6' (H) ], 134 . 26 , 134 . 37 and 134. 54 [ C -1' (B), C -1' (E) 
and C-1' (H)], 147 . 89, 148.33, 149.04, 149 . 67, 149.74, 150.39, 
150 . 54 , 150 . 69 , 150 . 77, 150 . 83 , 151. 3 6 and 154 . 9 9 [ C - 5 (A) , 
-5(D), -5(G), - 7(A), - 7(D), - 7(G), -9(A), -9(D), -9(G), 
_ 4' (B), - 4' (E) and - 4' (H) ], 16 7 . 34 - 170 . 3 7 [11 X O.cOCH 3] . 
7 -0Me - epiafzelechin-(4~~8,2~~0~7) - ent - afzelechin (42) .This is 
a white crystalline solid, mp 245-247°C, Rf 0.24 
[CH 2C1 2-acetone (70:30)]; FAB-MS m/ z 559 [M+H]+; (Found: C, 
63.69; H, 5 . 07 . C31H 2 6010·H20 requires C, 63.59; H, 4.59%); 
IRvm ax cm - 1 : 3522, 3302, 1628, 
23 
1144; [cx]D +67.65 0 (MeOH; c 
0.136), [cx ] ~:8 +70.95 0 (MeOH; c 0 . 136); IHNMR (CD 30D): 02.65 
[lH, dd , J=8.34, 16.37Hz, H-4(F) eq], 3 . 00 [lH, dd , J=5.47, 
16.37Hz, H-4(F) ax ] , 3 . 68 [3H, 5 , OMe-7(A)], 4.15 [lH, d , 
J=3 . 52Hz, H-3(C)] , 4.21 [lH, ddd , J=8.34, 5.49, 7 . 82Hz, 
H-3(F)], 4 . 36 [lH, d , J=3 . 52Hz, H- 4(C)], 4.84 [lH, d , 
J=7.82Hz, H-2(F)], 6.11 [lH, d , J=2.42Hz, H-6(A)], 6 . 18 [lH, 
5 , H-6(D)], 6.25 [lH, d , J=2 . 42Hz, H-8(A)], 6.88 [2H, d , 
J=8 . 79Hz, H-3',5'(B)], 6.88 [2H, d , J=8.56Hz, H-3',5'(E)], 
7.35 [2H, d , J=8.56Hz, H-2',6'(E)], 7.58 [2H, d , J=8.79Hz, 
H - 2' , 6' (B) ]; 1 3 CNMR ( CD 3 OD): 02 9 . 15 [ C - 4 (C) and C - 4 (F) ] , 
55.63 [OMe-7(A)], 67.49 [C - 3(C)], 67.97 [C-3(F)], 84 . 06 
[C-2(F)], 96.02 [C-8(A)], 96.59 [C-6(D)], 96 . 95 [C-6(A)], 
100.42 [C-2(C)], 103.15 [C-10(D)], 104 . 96 [C-10(A)], 106.53 
[C-8(D)], 115.52 [C - 3',5'(B)], 116 . 26 [C-3',5'(E)], 129.46 
[C-2',6'(B)], 129.74 [C-1'(E)], 130 . 12 [C-2',6'(E)], 131.42 
[C-1' (B) ], 151. 40 [C-9 (D) ], 152 . 03 [C-7 (D) ], 154 . 21 [C-9 (A) ] , 
155 . 98 [C-5 (D) ], 156 . 60 [C-5 (A) ], 158.56 [C-4' (E) ], 158.68 
[C-4' (B)], 160.84 [C-7(A)]. 
7 -0Me-epiafzelechin - (4~~8,2~~0~7) -ent-afzelechin - hexa-acetate 
(42a). Acetylation of (42) afforded the hexa-acetate as an 
amorphous solid, mp 145°C, Rf 0.37 [CH 2C1 2-acetone (97:3)]; 
[cx]~o-101.34° (CHC1 3 ; c 0.372) [cx]~~6-121.23° (CHC1 3 ; c 
o . 3 72) i I R v In a x cm - 1 : 1 7 60 , 162 6 , 13 71 , 1200 1063, 849 i HNMR 
(CDC1 3): 81 . 78 and 1.76 [each 3H, 5, OAc-3 (C) and -3 (F) ] , 
2.04 [3H, 
OAc-4' (B) , 
87 
s, OAc-5(A)], 2.24, 2.28 and 2 . 31 [each 3H, s, 
_ 4' (E) and - 5 (D) ], 2. 60 [ 2 H , m, 4 (F) ], 3. 78 [3 H , 
s, OMe-7(A)], 4.60 [lH, d, J=3.95Hz, H-4(C)], 5.28-5.35 [3H, 
overlapping signals, H-2(F), -3(F) and -3(C)], 6 . 12 [lH, d, 
J=2.43Hz, H-6(A)], 6.47 [lH, s, H-6(D)], 6.60 [lH, d, 
J=2.43Hz, H-8(A)], 7.02 [2H, d, J=8.81Hz, H-3',5'(E)], 7.16 
[2H, d, J=8.87Hz, H-3',5'(B)], 7 . 24 [2H, d, J=8.81Hz, 
H - 2' , 6' (E) ], 7 . 72 [ 2 H , d , J = 8 . 87 Hz, H - 2' , 6' (B) ]; l3 CNMR 
(CDC1 3): 820.15,-21.14 [6 X OCOQH3]' 22.36 [C-4(F)], 27.03 
[ C - 4 (C) ], 55. 20 [OMe - 7 (A) ], 67 . 25 [ C - 3 (C) ], 68. 28 [ C - 3 (F) ] , 
78.46 [C-2(F)], 97.86 [C-2(C)]' 99.62 [C-8(A)], 102.54 
[C-6(A)], 103.43 [C-6(D)], 105 . 68 [C-10(D)], 108.16 
[C-10 (A) ], 109.51 [C-8 (D) ], 121.11 [C-3' ,5' (B) ], 121. 64 
[C-3',5'(E)], 127.45 [C-2',6'(E)], 128.24 [C-2', 6' (B)], 
134 . 75 and 134. 88 [ C -1' (B) and C - l' (E) ], 148 . 82 [ C - 5 (D) ] , 
149.18 [C-5(A)], 150.43, 150.65 and 150.69 [C-7(D), C-9(D) 
and C - 4' (E) ] , 151 . 38 [C - 4' (B) ] , 153 . 94 [ C - 9 (A) ] , 
159.49 [C-7(A)], 168.57-170 . 46 [6 X OQOCH 3]. 
Base catalysed conversion of 7-0Me-epiafzelechin-
(4~~8,2~~0~7) -ent-afzelechin (42).A mixture of (42) (200mg) 
and K 2 C0 3 (ca. 300mg) was refluxed in acetone (ca. 4ml) for 
8,5 hours. After removal of potassium carbonate by 
filtration, the filtrate was concentrated to dryness. The 
residue was subj ect to chromatography over silica gel to 
afford two new compounds (60) (80mg) and (61) (40mg). 
7-0Me-epiafzelechin-(4~~6,2~~0~7) -ent-afzelechin (60) . This is 
a white amorphous powder, mp 230-234·C, Rf 0.22 
[CH 2 C1 2 -acetone (70:30)]; IRvma xcm - 1 : 3474, 1603, 1517, 1144; 
2 0 
(MeOH; [0]~~8 +33.57· [olD +31.71· c 0.432) , (MeOH; c 0.432) ; 
IHNMR (CD 30D) : 82.79 [2H, ddd, H-4(F)], 3.73 [3H, s, 
OMe-7 (A)] , 4.10 [lH, m, H-3(F)], 4.20 [lH, d, J=3.62Hz, 
H-3(C)], 4.37 [lH, d, J=3.62Hz, H-4(C)], 6.12 [1H, s, 
H-8(D)], 6.14 [lH, d, J=2.26Hz, H-6(A)], 6.25 [lH, d, 
J=2.26Hz, H-8(A)], 6 . 81 [2H, d, J=8.60Hz, H-3' ,5' (E)], 6 . 88 
[2H, d, J=8.84Hz, H-3' ,5' (B)], 7.23 [2H, d, J=8.60Hz, 
88 
H-2',6'(E)], 7.59 [2H, d, J=8.84Hz, H-2',6'(B)]; 13CNMR 
(CD 30D): 028.40 [C-4 (F) ], 29.72 [C-4 (C) ], 55.75 [OMe-7 (A) ] , 
67.38 [C-3(C)]' 68.43 [C-3(F)], 82.54 [C-2(F)], 94.89 
[ C - 8 (A)], 95 . 99 [ C - 8 (D)], 96 . 6 6 [ C - 6 (A)], 100 . 75 [ C - 2 (C) ], 
103.66 [C-10(D)], 105.27 [C-10(A)], 108.53 [C-6(D)], 116.03 
[C-3',5'(B)], 116.06 [C-3',5'(E)], 129.29 [C-2',6'(E)], 
129.64 [C-2',6'(B)], 131.30 [C-1'(E)], 13l.43 [C-1'(B)], 
15l.92 [C-9(D)], 152.43,152.45 and 155.21 [C-5(A), C-7(D) 
and C - 5 (D) ] , 154 . 52 [ C - 9 (A) ] , 15 8 . 2 6 [ C - 4' (E) ] , 15 8 . 8 9 
[C-4'(B)], 160.96 [C-7(A)]. 
7-0Me-epiafzelechin- (413~6,213~0~7) -epiafzelechin (61) .This is 
a white amorphous powder, mp 241-244'C, Rf 0.32 
[CH 2Cl r acetone (70:30)]; IRvmaxcm-
1 : 3474,1603,1517,1144; 
[cxl~o+49.17' (MeOH; c 0.120), [cxl~~8 +52.50' (MeOH; c 0.120); 
IHNMR (CD 30D): 02.93 [2H, m, H-4 (F)], 3.74 [3H, s, OMe-7 (A)] , 
4.19 [lH, m, H-3(F)], 4.20 [lH, d, J=3.58Hz, H-3(C)], 4.38 
[lH, d, J=3.58Hz, H-4(C)], 4.88 [lH, brs, H-2(F)], 6.12 [lH, 
d, J=2.21Hz, H-6(A)], 6.17 [lH, s, H-8(D)], 6.24 [lH, d, 
J=2.21Hz, H-8(A)], 6.88 [2H, d, J=8.60Hz, H-3',5' (E)], 6.88 
[2H, d, J=8.88Hz, H-3',5'(B)], 7.33 [2H, d, J=8.60Hz, 
H-2',6'(E)], 7.58 [2H, d, J=8.88Hz, H-2',6'(B)J; 13CNMR 
(CD 30D): 029.78 [C-4 (C) and C-4 (F)], 55.76 [OMe-7 (A)], 66.99 
[C-3(F)], 67.41 [C-3(C)], 79.88 [C-2(F)], 94.89 [C-8(A)], 
95 . 95 [ C - 6 (A) ], 9 6 . 9 8 [ C - 8 (D) ], 100 . 72 [ C - 2 (C) ], 102 . 74 
[C-10(D)], 105.33 [C-10(A)], 108.60 [C-6(D)], 115.53 
[C-3',5'(B)], 115.72 [C-3',5'(E)], 129.10 [C-2',6'(E)], 
129.64 [C-2',6'(B)], 131.39 [C-1'(E)], 13l.49 [C-l'(B)], 
151.90 [C-9 (D) ], 152.93 [C-5 (D) ], 154.54 [C-9 (A) ], 155.20 
[C-5 (A) ] , 155.83 [C-7 (D) ] , 157.88 [C-4' (E) ] , 158.92 
[C-4'(B)], 160.99 [C-7(A)]. 
7-0Me-epiafzelechin- (413~8,213~0~7) -epiafzelechin (43) .This is 
a white crystalline solid, mp 235-237'C, Rf 0.56 
[CH 2C1 2-acetone (55:45)]; FAB-MS m/z 559 [M+H]+; (Found: C, 
62.56; H, 5.41. C31H26010·2H20 requires C, 62.62; H, 5.085%); 
89 
IRv rnax cm-
1 : 3373, 1626, 1516, 1142; [cx]~3+57.81° (MeOH; c 
0.192), [cx]~~8+60 . 42° (MeOH; c 0.192); IHNMR (CD 30D): 82.79 
[lH, dd, J=2.45, 17.40Hz, H-4(F) eq], 2.99 [lH, dd, J=4.59, 
17.40Hz, H-4(F)a x] , 3.73 [3H, s , OMe-7(A)], 4.12 [lH, d , 
J=3.34Hz, H-3(C)], 4 .25 [lH, m, H - 3 (F) ], 4 .49 [lH, d , 
J=3.34Hz, H-4(C)], 4.99 [lH, s , H-2(F)] , 6.13 [lH, d , 
J=1.85Hz, H-6(A)] , 6.14 [lH, s , H-6(D)], 6 . 22 [lH, d , 
J=1 . 85Hz, H-8(A)], 6.86 [2H, d , J=8.84Hz, H-3' ,5' (B)], 6.87 
[2H, d, J=8.66Hz, H-3',5'(E)], 7.54 [2H, d , J=8.66Hz, 
H-2',6'(E)], 7.55 [2H, d , J=8.84Hz, H-2',6'(B)]; 13CNMR 
(CD 30D ): 829.63 [C-4(C)], 30.27 [C-4(F)], 56.04 [OMe-7(A)], 
67.36 [C-3(F)], 68.29 [C-3(C)]' 81.94 [C-2(F)], 96.48 
[ C - 8 (A) ], 96 . 83 [ C - 6 (D) ], 96 . 93 [ C - 6 (A) ], 100 . 68 [ C - 2 (C) ] , 
102.75 [C-10(D)], 105.59 [C-10(A)], 107.36 [C-8(D)], 115.87 
[C-3',5'(B)], 116.25 [C-3',5'(E)], 129.81 [C-2',6'(B)], 
130.29 [C-2',6'(E)], 130.96 [C-1'(E)], 132.08 [C-1'(B)], 
152.56 [C-9 (D)], 154.60, 156.90, 156.94 and 157.361 [C-5 (A) , 
C-5(D), C-7(A) and C-7(D)], 158.59 [C-4'(E)], 159 . 19 
[C-4' (B)], 161.20 [C-7 (A)] . 
7 -0Me-epiafzelechin-(4~~8,2~~0~7) -epiafzelechin-hexa-acetate 
(43a). Acetylation of (43) afforded the hexa-acetate as an 
amorphous solid, mp 125-127°C, Rf 0.26 [CH 2 Cl r acetone 
(97:3)]; [cx]~o-80.10° (CHC1 3 ; c 0.206) [cx]~~6-95.15° (CHC1 3 i c 
0.206); HNMR (CDC1 3): 81.46 and 1. 73 [each 3H, s, OAc-3 (C) 
and -3(F)], 1.95 [3H, s, OAc-5(A)], 2.27, 2.30 and 2.31 [each 
3H, s, OAc-4'(B), -4'(E) and -5(D)], 2.88 [2H, m, 4(F)], 3.80 
[3H, s, OMe-7(A)], 4.54 [lH, d, J=4.00Hz, H-4(C)], 5.22-5.31 
[3H, overlapping signals, H-2(F), -3(F) and -3(C)], 6.26 [lH, 
d, J=2.47Hz, H-6(A)], 6.49 [lH, s, H-6(D)], 6.60 [lH, d, 
J=2.47Hz, H-8(A)], 7.12 [2H, d, J=8.66Hz, H-3',5'(E)], 7.16 
[2H, d, J=8.88Hz, H-3',5'(B)], 7.49 [2H, d, J=8.66Hz, 
H-2',6'(E)], 7.70 [2H, d, J=8.88Hz, H-2',6'(B)]; 13CNMR 
(CDC1 3): 819.72,-21.17 [6 X OCO.cH 3], 25.47 [C-4(F)], 27.11 
[C-4(C)], 55.52 [OMe-7(A)], 66 . 62 [C-3(F)], 67.79 [C-3(C)], 
77.82 [C-2(F)], 98.09 [C-2(C)], 99.30 [C-8(A)], 102.78 
90 
[C-6(A)], 103.68 [C-6(D)], 105.59 [C-10(D)], 108.15 
[C-10(A)], 109.69 [C-8(D)]' 121.11 [C-3',5'(B)], 121.32 
[C-3',5'(E)], 128.26 [C-2',6'(B)], 129.22 [C-2',6'(E)], 
134 . 1 7 [ C - l' (E)] 134. 59 [ C -1' (B)] , 149. 20 and 150. 25 [C - 5 (D) 
and C-7(D)], 149.37 [C-5(A)], 150.96 [C-4'(E)], 151.37 
[C - 4' (B) ], 152. 00 [C - 9 (D) ], 154. 15 [ C - 9 ( A) ], 168. 73 - 170 . 31 [ 6 
X 0.cOCH3] . 
Kaempferol-3-0-a-L-rhamnopyranoside (44). This 
yellow amorphous powder, mp 167-170°C, 
[CH2C12-acetone (55:45)]; FAB-MS m/z 434 [M+H]+; 
is a pale 
Rf 0.15 
[a]~4 -140.6° 
(MeOH; c 0.348); IR vrnaxcm- 1 : 1610, 1362, 1176, 973; IHNMR 
(CD 30D): 00.96 [lH, d, J=5.79Hz, H-6"], 3.35-3.40 [each 1H, 
H-4", H-5"], 3.77 [lH, dd, J=3.39, 9.32Hz, H-3"], 4.28 [lH, 
dd, J=3.39, 1.74Hz, H-2"], 5.41 [lH, d, J=1.74Hz, H-1"], 6.19 
[lH, d, J=2.1Hz, H-6(A)], 6.35 [lH, d, J=2.1Hz, H-8(A)], 6.95 
[2H, d, J=8.90Hz, H-3',5'(B)], 7.77 [2H, d, J=8.90Hz, 
H - 2' , 6' (B) ]; 1 3 CNMR ( CD 3 OD): 017 . 63 [ C - 6 "], 71. 86 , 71. 94 , 
72.05 and 73.15 [C-2", C-3", C-4" and C-5"], 94.73 [C-8(A)], 
99.78 [C-6(A)], 103.39 [C-1"], 105.85 [C-10(A)], 116.43 
[C-3' ,5' (B)], 122.55 [C-1' (B)], 131. 86 [C-2', 6' (B)], 136.13 
[C-3(C)], 158.36 [C-9(A)], 159.13 [C-2(C)], 161.40 [C-4'(B)], 
163.03 [C-5(A)], 165.67 [C-7(A)], 179.45 [C-4(C)]. 
Kaempferol-3-0-a-L-rhamnopyranoside-hexa-acetate (44a) . 
Acetylation of (44) according to standard procedures yielded 
(44a) as an amorphous powder, mp 99°C, Rf 0.20 
[CH 2Cl r acetone (97:3)]; [a]~3-154.55° (CHC1 3 ; c 
0.220) [a]~:6 -197.27° (CHC1 3 ; c 0.220); IR vrnaxcm-l: 1753, 
1629, 1371, 1215; IHNMR (CDC1 3): 00.872 [3H, d, J=6.30Hz, 
H-6"], 1.985, 1.991, 2.13, 2.33, 2.34 and 2.44 [each 3H, 5, 6 
X OAc], 3.26 [lH, dq, J=9.87, 6.30Hz, H-5"], 4.92 [lH, dd, 
J=1.00, 9.87Hz, H-4"], 5.25 [lH, dd, J=3.38, 1000Hz, H-3"], 
5.58 [lH, d, J=1.78Hz, H-1"], 5.65 [lH, dd, J=1.78, 3.38Hz, 
H-2"], 6.85 [lH, d, J=2.24Hz, H-6(A)], 7.29 [lH, d, J=2.24Hz, 
H-8(A)], 7.29 [2H, d, J=8.97Hz, H-3',5'(B)II] 7.92 [2H, d, 
J=8.97Hz, H-2' ,6' (B) II] ; 13CNMR (CDC1 3): 017.00 [C-6"], 20.66, 
91 
20.73,20.90,21.0821.10 and 21.17 [6 X OCO.c.H3], 68.42 
[C-5"], 68.82 and 69.07 [C-2" and C-3"], 70.25 [C-4"], 98.04 
[C-1"], 108.98 [C-8(A)], 113.60 [C-6(A)], 115.14 [C-10(A)], 
122.21 [C-3',5'(B)], 127.45 [C-1'(B)], 130 . 17 [C-2',6'(B)], 
136 . 96 [ C - 3 (C) ], 150 . 35 , 152 . 74 , 153. 94 , 155 . 30 and 156. 67 
[ C - 4' (B), C - 9 (A), C - 7 (A), C - 5 ( A) and C - 2 (C) ], 168. 0 I, 168 . 70, 
169.41, 169.65, 169.96 and 170.03 [6 X 0.c.OCH 3], 172.25 
[C-4 (C)] . 
4' -OMe-epigallocatechin (45) this is a reddish brown 
crystalline solid, mp 144°C, Rf 0.3 [CH 2C1 2 -acetone (55:45)] i 
FAB-MS m/ z 321 [M+H] + i [a]~3 -60.000 (EtOHi c 
0.12), [al ~ :6 -76.67° (EtOHi c 0.12) i I HNMR (CD 30D): 02.75 [lH, 
dd, J= 2.9, 16.8Hz, H-4(C) eq], 2.91 [lH, dd, J=4.3, 16.8Hz, 
H-4(C) ax ], 3.82 [lH, s, OMe-4'(B)], 4.21 [lH, m, H-3(C)], 
4.80 [lH, brs, H-2(C)], 5 . 96 [lH, d, J=2.2Hz, H-6(A)], 5.98 
[lH, d, J=2.2Hz, H-8(A)], 6.56 [2H, s, H-2',6'(B)]i 1 3CNMR 
( CD 3 OD): 82 9 . 49 [ C - 4 (C) ], 61. 08 [ OMe - 4' (B) ], 6 7 . 70 [ C - 3 (C) ] , 
79 . 96 [ C - 2 (C) ], 96 . 18 [ C - 6 (A) ], 96 . 72 [ C - 8 (A) ], 100 . 35 
[C-10(A)], 107.46 [C-2',6'(B)], 136 . 37 [C-4'(B)], 136 . 92 
[ C - I' (B) ] , 151. 67 [ C - 3' , 5' (B) ], 15 7 . 4 6 , 157 . 97 , and 158 . 2 8 
[C-5 (A), C-7 (A), and C-9 (A)] . 
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APPENDIX-NMR SPECTRA 
1.1. Afzelechin, lHNMR spectrum (acetone-d 6 ) 
1.2 . Afzelechin, 13CNMR spectrum (acetone-d 6 ) 
2.1 . Epiafzelechin, lHNMR spectrum (acetone-d 6 ) 
2.2. Epiafzelechin, 13CNMR spectrum (acetone-d 6 ) 
3.1 . Epiafzelechin-(4~~8,2~~O~7)-epiafzelechin, lHNMR 
spectrum (CD30D) 
3.2. Epiafzelechin-(4~~8,2~~O~7)-epiafzelechin, 13CNMR 
spectrum (CD30D) 
3.3 Epiafzelechin-(4~~8,2~~O~7)-epiafzelechin, HETCOR 
spectrum (CD30D) 
4.1. Epiafzelechin-(4~~8,2~~O~7)-epiafzelechin-pentamethyl 
ether, lHNMR spectrum (CDC13) 
4.2. Epiafzelechin-(4~~8,2~~O~7)-epiafzelechin-pentamethyl 
ether, 13CNMR spectrum (CDC1 3) 
4.3. Epiafzelechin-(4~~8,2~~O~7)-epiafzelechin-pentamethyl 
ether, lH_1H COSY spectrum (CDC1 3) 
4.4 . Epiafzelechin-(4~~8,2~~O~7)-epiafzelechin-pentamethyl 
ether, HETCOR spectrum (CDC1 3) 
4.5. Epiafzelechin-(4~~8,2~~O~7)-epiafzelechin-pentamethyl 
ether, DELAYED HETCOR spectrum (7.5Hz) (CDC1 3) 
5.1. Epiafzelechin-(4~~8,2~~O~7)-epiafzelechin-pentamethyl 
ether diacetate, lHNMR spectrum (CDC1 3) 
5.2. Epiafzelechin-(4~~8,2~~O~7)-epiafzelechin-pentamethyl 
ether diacetate, 13CNMR spectrum (CDC1 3) 
5.3. Epiafzelechin-(4~~8,2~~O~7)-epiafzelechin-pentamethyl 
ether diacetate, lH_1H DELAYED COSY spectrum (O.lsec) 
(CDC1 3) 
5.4. Epiafzelechin-(4~~8,2~~O~7)-epiafzelechin-pentamethyl 
ether diacetate, HETCOR spectrum (CDC1 3) 
5.5. Epiafzelechin-(4~~8,2~~O~7)-epiafzelechin-pentamethyl 
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ether diacetate, DELAYED HETCOR spectrum (7Hz) (CDC1 3) 
6.1. Afzelechin-3-0-a-L-rhamnopyranoside, lHNMR spectrum 
(acetone-d 6 + D20) 
6.2. Afzelechin-3-0-a-L-rhamnopyranoside, 13CNMR spectrum 







8 . 2. 











Afzelechin-3-0-a-L-rhamnopyranoside, IH-IH DELAYED 
COSY spectrum (5Hz) (acetone-d 6 ) 
Afzelechin-3-0-a-L-rhamnopyranoside, HETCOR 
spectrum (5Hz) (acetone-d 6 ) 
Afzelechin-3-0-a-L-rhamnopyranoside hexa-acetate, 
IHNMR spectrum (CDC1 3) 
Afzelechin-3-0-a-L-rhamnopyranoside hexa-acetate, 
13CNMR spectrum (CDC1 3) 
Afzelechin-3-0-a-L-rhamnopyranoside hexa-acetate, 




spectrum (CD 30D) 
Epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin, HETCOR 
spectrum (CD 30D) 
Epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin, 
100 
DELAYED HETCOR spectrum (7Hz) (CD 30D) 
Epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin-tetramethyl 
ether, IHNMR spectrum (CDC1 3) 
Epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin-tetramethyl 
ether, 13CNMR spectrum (CDC1 3) 
Epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin-tetramethyl 
ether, IH_IH COSY spectrum (CDC1 3) 
Epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin-tetramethyl 
ether, HETCOR spectrum (CDC1 3) 
Epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin-tetramethyl 
ether, DELAYED HETCOR spectrum (7Hz) (CDC1 3) 
Epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin-heptamethyl 
ether, IHNMR spectrum (CDC1 3) 
Epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin-heptamethyl 
ether, 13CNMR spectrum (CDC1 3) 
EpiafzeleChin-(4~~8,2~~0~7)-ent-afzelechin-tetramethYl 
ether, IH_IH COSY spectrum (CDC1 3) 
EpiafzeleChin-(4~~8,2~~0~7)-ent-afzelechin-heptamethyl 
ether, HETCOR spectrum (CDC1 3) 
10.5. 
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13 . 3 . 
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ether, DELAYED HETCOR spectrum (6Hz) (CDC1 3) 
Epiafzelechin-(4~~6)-epiafzelechin-(4~~8,2~~0~7)-ent­
afzelechin peracetate, lHNMR spectrum (CDC1 3) 
Epiafzelechin-(4~~6)-epiafzelechin-(4~~8,2~~0~7)-ent­
afzelechin peracetate, lHNMR spectrum 06.4-7.8 (CDC1 3) 
Epiafzelechin-(4~~6)-epiafzelechin-(4~~8,2~~0~7)-ent­
afzelechin peracetate, 13CNMR spectrum (CDC1 3) 
Epiafzelechin-(4~~6)-epiafzelechin-(4~~8,2~~0~7)-ent­
afzelechin peracetate, lH_1H COSY spectrum (CDC1 3) 
Epiafzelechin-(4~~6)-epiafzelechin-(4~~8,2~~0~7)-ent­
afzelechin peracetate, lH-1H COSY spectrum 02.5-5 . 8 
(CDC1 3) 
Epiafzelechin-(4~~6)-epiafzelechin-(4~~8,2~~0~7)-ent­
afzelechin peracetate, lH-1H DELAYED COSY spectrum 
(CDC1 3) 
Epiafzelechin-4~-benzylthioether, lHNMR 
spectrum (CD 30D) 
Epiafzelechin-4~-benzylthioether, 13CNMR 
spectrum (CD 30D) 
7-0Me-epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin, 
lHNMR spectrum (CD 30D) 
7-0Me-epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin, 
13CNMR spectrum (CD 30D ) 
7-0Me-epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin, 
lH_1H DELAYED COSY spectrum (2.5Hz) (CD 30D) 
7-0Me-epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin, 
DELAYED HETCOR spectrum (7Hz) (CD 30D) 
7-0Me-epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin­
hexa-acetate, lHNMR spectrum (CDC1 3) 
7-0Me-epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin_ 
hexa-acetate, 1 3CNMR spectrum (CDC1 3) 
7-0Me-epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin_ 
hexa-acetate, HETCOR spectrum (CDC1 3) 
7-0Me-epiafzelechin-(4~~8,2~~0~7)-ent-afzelechin_ 
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IHNMR spectrum (CD 30D) 
7-0Me-epiafzelechin-(4~~6,2~~O~7)-ent-afzelechin, 
13CNMR spectrum (CD30D) 
7-0Me-epiafzelechin-(4~~6,2~ ~O~7)-ent-afzelechin, 
HETCOR spectrum (CD 30D ) 
7-0Me-epiafzelechin-(4~~6,2~~O~7)-ent-afzelechin, 
DELAYED HETCOR spectrum (7.5Hz) (CD 30D) 
7-0Me-epiafzelechin- (4~~6,2~~O~7)-epiafzelechin, 
IHNMR spectrum (CD30D) 
7-0Me-epiafzelechin-(4~~6,2~~O~7)-epiafzelechin, 
13CNMR spectrum (CD30D) 
7-0Me-epiafzelechin-(4~~6,2~~O~7)-epiafzelechin, 
HETCOR spectrum (CD 30D) 
7-0Me-epiafzelechin-(4~~6,2~~O~7)-epiafzelechin, 
DELAYED HETCOR spectrum (7.5Hz) (CD 30D) 
7-0Me-epiafzelechin-(4~~8,2~~O~7)-epiafzelechin, 
IHNMR spectrum (CD 30D) 
7 - 0Me-epiafzelechin-(4~~8,2~~O~7)-epiafzelechin, 
13CNMR spectrum (CD30D) 
7-0Me-epiafzelechin-(4~~8,2~~O~7)-epiafzelechin, 
DELAYED HETCOR spectrum (7Hz) (CD 30D) 
7-0Me-epiafzelechin-(4~~8,2~~O~7)-epiafzelechin­
hexa-acetate, IHNMR spectrum (CDC1 3) 
7-0Me-epiafzelechin-(4~~8,2~~O~7)-epiafzelechin­
hexa-acetate, 13CNMR spectrum (CDC1 3) 
7-0Me-epiafzelechin-(4~~8,2~~O~7) -epiafzelechin-
hexa-acetate, HETCOR spectrum (CDC1 3) 
7-0Me-epiafzelechin-(4~~8,2~~O~7) -epiafzelechin-
hexa-acetate, DELAYED HETCOR spectrum (7Hz) (CDC1 3) 
Kaempferol-3-0-a-L-rhamnopyranoside, IHNMR spectrum 
(CD 30D) 
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Kaempferol-3-0-a-L-rhamnopyranoside, 13CNMR spectrum 
(CD 30D) 
Kaempferol-3-0-a-L-rhamnopyranoside, IH_IH COSY 






21. 3 . 
21.4. 
Kaempferol-3-0-a-L-rhamnopyranoside, HETCOR spectrum 
(CD30D ) 
Kaempferol-3-0-a-L-rhamnopyranoside-hexa-acetate, 
lHNMR spectrum (CDC13) 
Kaempferol-3-0-a-L-rhamnopyranoside-hexa-acetate, 
13CNMR spectrum (CDC13) 
4'-OMe-epigallocatechin, lHNMR spectrum 
(CD 30D) 
4'-OMe-epigallocatechin, 13CNMR spectrum 
(CD 30D) 
4'-OMe-epigallocatechin, HETCOR spectrum 
(CD 30D) 
103 
4'-OMe-epigallocatechin, DELAYED HETCOR spectrum (7Hz) 
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5.3. Epiafzelechin-(4~48,2~4Q47)-eptafzelechin-pentam~thyl ether diacetate lH_1H DELAYED COSY spectrum (O.lsec) (CDCl 3 ) 
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5.4. Epiafzelechin-(4~~8, 2~~~7) -epiafzelechin-pentamethyl ether diacetate HETCOR spectrum (CDCl 3 ) 
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5.5. Epiafzelechin-(4~~8.2~~~7)-epiafzelechin-penta~ethyl ether diacetate DELAYED HETCOR spectrum (7Hz) (CDC1 3 ) 
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8.2. Epiafzelechin-(4~~8,2~4Q~7)-ent-afzelechin 1.3 CNMR spectrum (CD
3
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9 . 2. Epiafzelechin-(4~48,2~~47)-ent-afzelechin-tetiamethyl ether 13 CN MR spectrum (CDC1 3 ) 
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9.3. Epiafzelechin-(4~~8,2~-o~7)-ent-afzelechin-tet~amethyl ether IH_IH COSY spectrum (CDC1 3 ) 
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9, 5, EpiafzeIechin-(4~~8,2~~~7)-ent-afzeIechin-tetramethyl ether DELAYED HETCOR spectrum (7Hz) (CDCI 3 ) 
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10 . 1 . Epiafze1echin-(4~~8 , 2~~~7)-ent-afze1echin-'heptamethy1 ether lHNMR spectrum (CDC1
3
) 
10.2 . Epiafzelechin - (4~~8,2~~~7)-ent-afze1echin-heptamethyl ether 13 CNMR spectrum (CDC1 3 ) 
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10 . 3. Epiafzelechin-(4~~8.2~~~7)-ent-afze1echin-heptamethyl ether lH_1H COSY spectrum (CDC1
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10_4_ Epiafze1echin-(4~~8,2~~~7)-ent-afzelechin-heptamethyl ether HETCOR spectrum (CDC1
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11 . 1. Epiafzelechin-(4~~6)-epiafzelechin-(4~~8,2~.~~7)-ent-afzelechin peracetate 
lHNMR spectrum (CDC1 3 ) 
2 1 PPM 
I I J-~ I -T I I I I I I I I i I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 
7.8 7.6 7.4 7.2 7.0 6.8 6.6 6.4 PPM 
11.2. Epiafze1echin-(4~~6)-epiafze1echin-(4~~8,2~~~7)-ent-afze1echin peracetate 
IHNMR spectrum 86.4-7.8 (CDCl
3
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11 . 3 . Epiafzelechin-(4~46)-epiafzelechin-(4~48 , 2~~~7)-ent-afzelechin peracetate 






























11.4, Epiafze1echin-(4~~6)-epiafze1echin-(4~~8,2~~~7)_ent_afzelechin peracetate 
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11.5. Epiafzelechin-(4~~6)-epiafzelechin-(4~~8,2~~~7)-ent-afzelechin peracetate 
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11_6_ Epiafzelechin-(4~~6)-epiafzelechin-(4~~8,2~~~7)-ent-afzelechin peracetate 
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12 . 1. Epiafze1echin-4~-benzy1thioether IHNMR spectrum (CD
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13.3. 7-0Me-epiafzelechin-(4~~8,2~~7)-ent-afzelechin DELAYED COSY spectrum (2 . 5Hz) (CD 30D) 
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14 , 1, 7-0Me-epiafze1echin-(4~48,2~~7)-ent-afze1echin-hexa-acetate IHNMR spectrum (CDC1 3 ) 
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14.2 . 7-0Me-epiafzelechin-(4~48,2~~7)-ent-afzelechin-hexa-acetate 13CNMR spectrum (CDCl 3 ) 
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14 . 3, 7-OMe- epiafze1echin-(4~~8 , 2~~7)-ent-afze1echin-hexa-acetate HETCOR spectrum (CDC1
3
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17.2. 7-0Me-epiafze1echin-(4~~8,2~~7)-epiafze1echin 13CNMR spectrum (CD
3
0D) 
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18.2. 7-0Me-epiafze1echin-(4~~8,2~~7)-epiafzelechin-hexa-acetate 13CNMR spectrum (CDC1 3 ) 
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18.3. 7·0Me·epiafzelechin·(4~~8,2~~7)·epiafzele~hin·hexa·acetate HETCOR spectrum (CDC1
3
) 
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18.4. 7-0Me-epiafzelechin-(4~~8.2~~7)-epiafzelechin-hexa-acetate DELAYED HETCOR spectrum (7Hz) (CDC1 3 ) 
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19.1 . Kaempferol-3-0-a-L-rhamnopyranoside l HNMR spectrum (CD 3 0D) 
r ···- -· · ·-- -·----·-·--·-·-- ·------ · - .... - - ._ .. -- - _.-.-.---.. - ·-----·---1 
1&1 a ! Q) , I 
: , I 
I " I ~ ., I 
1° ; ... 





















I --_.- - · -1·- . ._-,- 6 
7 
en 






CI 'D. ID I 








~QI. I ... 
o e ~=B 
- -· -r·-··-·--- -,-- -. . - · ·-1 - .. - ----1-· · - - -.-- r :E 






19.3. Kaempferol-3-0-o-L-rhamnopyranoside lH_1 H COSY spectrum (CD 3 0D) 
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21.3 , 4' -OMe-epigallocatechin HETCOR spectrum (CD~OD) 
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21_4. 4'-OMe-epigallocatechin DELAYED HETCOR spectrum (10Hz) (CD
3
0D) 
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